var title_f43_39_44656="Progression vasc neuropathy";
var content_f43_39_44656=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F75374&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F75374&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Progression of vasculitic neuropathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 402px; height: 300px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Vasculitic neuropathy begins by involvement of both sensory (hashed areas) and motor nerve (black areas) distribution. As the process progresses (moving left to right on the figure), it becomes more confluent and symmetrical.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John H Stone, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_39_44656=[""].join("\n");
var outline_f43_39_44656=null;
var title_f43_39_44657="Subcutaneous paragonimiasis - finger";
var content_f43_39_44657=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F73458&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F73458&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Subcutaneous paragonimiasis - finger",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 355px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The left fifth finger showing an erythematous swelling on the tip.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Sim YS, Lee JH, Hong SC, et al. Paragonimus westermani found in the tip of a little finger. Intern Med 2010; 49:1645. Copyright &copy; 2010 Japanese Society of Internal Medicine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_39_44657=[""].join("\n");
var outline_f43_39_44657=null;
var title_f43_39_44658="Preventing opportunistic infections in HIV";
var content_f43_39_44658=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Preventing opportunistic infections in HIV (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?43/39/44658/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/39/44658/contributors\" id=\"au136\">",
"       John G Bartlett, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?43/39/44658/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/39/44658/contributors\" id=\"se636\">",
"       Martin S Hirsch, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?43/39/44658/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/39/44658/contributors\" id=\"de1919\">",
"       Anna R Thorner, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?43/39/44658?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      INTRODUCTION",
"     </span>",
"    </p>",
"    <p>",
"     Infection with HIV reduces the immune system's ability to fight infections. Certain bacteria, viruses, fungi, and other organisms, which do not usually cause infections in healthy people, can cause infections in people with a weakened immune system; these are called opportunistic infections. One way to measure the strength of the immune system of a patient with HIV is to measure the T cell count (also called the CD4 count). When the T cell count is below 200 cells, the patient has developed AIDS and is at risk for opportunistic infections. However, opportunistic infections can be prevented by taking certain antibiotics and antifungal medications. HIV medications can also boost the T cell count up so the risk of opportunistic infections can decline with ongoing treatment. An explanation of T cell counts is available in a separate topic review. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?15/31/15861?source=see_link\">",
"      \"Patient information: Initial treatment of HIV (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Other topic reviews about the treatment of HIV are available separately. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?15/31/15861?source=see_link\">",
"      \"Patient information: Initial treatment of HIV (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/56/2946?source=see_link\">",
"      \"Patient information: Tips for taking HIV medications (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      PNEUMOCYSTIS",
"     </span>",
"    </p>",
"    <p>",
"     Pneumocystis (pronounced new-mow-SIS-tis) carinii pneumonia (PCP) is an opportunistic infection of the lungs. It is the leading AIDS-related cause of pneumonia and death. It is possible to prevent most cases of PCP by taking an antibiotic.",
"    </p>",
"    <p>",
"     Preventive treatment is strongly recommended for people with a low T cell count (usually less than 200",
"     <span class=\"nowrap\">",
"      cells/microL),",
"     </span>",
"     a history of PCP pneumonia, or a history of thrush (a yeast infection in the mouth).",
"    </p>",
"    <p>",
"     People who begin antiretroviral therapy for HIV may discontinue PCP preventive therapy when their T cell count is greater than 200",
"     <span class=\"nowrap\">",
"      cells/microL",
"     </span>",
"     for at least three months. However, lifelong preventive treatment may be recommended for people who developed PCP when the T cell count was greater than 200",
"     <span class=\"nowrap\">",
"      cells/microL.",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      TOXOPLASMA",
"     </span>",
"    </p>",
"    <p>",
"     Toxoplasmosis is an infection that is found worldwide and usually causes infection without any major symptoms. However, the parasite persists in the body and can cause a life-threatening infection in the brain in patients with AIDS. A blood test is recommended after HIV is diagnosed to determine if a person has been exposed to the Toxoplasma parasite previously. Preventive treatment is recommended if the T cell count is less than 100",
"     <span class=\"nowrap\">",
"      cells/microL.",
"     </span>",
"    </p>",
"    <p>",
"     If the blood test shows that the patient has never had toxoplasmosis infection in the past, it is important to avoid exposure. Common sources of the parasite include raw or rarely cooked meat, cat stool, and soil.",
"    </p>",
"    <p>",
"     If an HIV-infected person has",
"     <strong>",
"      not",
"     </strong>",
"     previously been exposed to Toxoplasma, measures to prevent infection are sometimes recommended, including the following:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Do not eat raw or rare lamb, beef, pork, or venison. Meat that is pink inside indicates that the meat is not adequately cooked; the internal temperature should be at least 165&ordm;F.",
"      </li>",
"      <li>",
"       Avoid changing cat litter; if someone cannot assist you, use gloves and wash hands when finished. Avoid touching stray cats.",
"      </li>",
"      <li>",
"       Wash hands after gardening.",
"      </li>",
"      <li>",
"       Wash hands and counter tops after preparing raw meat or poultry.",
"      </li>",
"      <li>",
"       Wash fruits and vegetables well before eating them raw.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      MYCOBACTERIUM AVIUM COMPLEX (MAC)",
"     </span>",
"    </p>",
"    <p>",
"     MAC is an opportunistic infection that can develop in people with HIV who have T cell counts below 50",
"     <span class=\"nowrap\">",
"      cells/microL.",
"     </span>",
"     MAC can cause high fevers, abdominal pain and weight loss.",
"    </p>",
"    <p>",
"     Mycobacterium avium can be found throughout the environment; it is not possible to prevent infection through personal protective measures. However, a preventive antibiotic can effectively prevent infection and is generally recommended for people with HIV when the T cell count is less than 50",
"     <span class=\"nowrap\">",
"      cells/microL.",
"     </span>",
"     Treatment can generally be discontinued when the T cell count is greater than 100",
"     <span class=\"nowrap\">",
"      cells/microL",
"     </span>",
"     for at least three months.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H5\">",
"     <span class=\"h1\">",
"      HISTOPLASMOSIS",
"     </span>",
"    </p>",
"    <p>",
"     Histoplasma is a fungus that grows in soil and areas contaminated with bat or bird droppings; it is more common in certain areas, such as the eastern and central United States. It can cause pneumonia in people with HIV who have a low T cell count and who live in an area where there is a high risk of infection (eg, areas of the midwestern United States and Puerto Rico).",
"    </p>",
"    <p>",
"     People who visit or live in these areas should avoid high risk activities, such as disturbing soil under bird roosting sites, demolishing old buildings, or exploring caves.",
"    </p>",
"    <p>",
"     A preventive antifungal treatment may be recommended to people who have a low T cell count (generally less than 150",
"     <span class=\"nowrap\">",
"      cells/microL)",
"     </span>",
"     who are at high risk of becoming infected; this would include people who live in areas where the infection is common.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      CANDIDA (YEAST)",
"     </span>",
"    </p>",
"    <p>",
"     Candida (yeast) infections of the mouth and vagina are more common in people with HIV. Yeast infections can also develop in other areas, such as in skin folds, in the groin, and around the anus.",
"    </p>",
"    <p>",
"     Preventive treatments for candida are not usually recommended unless you have frequent infections. Yeast infections in women are discussed in detail in a separate topic review. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/53/2899?source=see_link\">",
"      \"Patient information: Vaginal yeast infection (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H7\">",
"     <span class=\"h1\">",
"      CRYPTOCOCCUS",
"     </span>",
"    </p>",
"    <p>",
"     Cryptococcus is a fungus that is found in the environment, particularly in soil frequented by birds. Infection with this fungus can lead to a lung infection called cryptococcosis (pronounced crip-toe-cah-COH-sis)",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     a severe brain infection (called cryptococcal meningitis). This infection is more common in people with a T cell count less than 100",
"     <span class=\"nowrap\">",
"      cells/microL.",
"     </span>",
"    </p>",
"    <p>",
"     Cryptococcal infection is the fourth most common opportunistic infection in people with AIDS. The number of cases of cryptococcosis has declined since effective antiretroviral treatments (ART) became available, although this infection is still a relatively common AIDS-defining illness in people who do not take HIV medications.",
"    </p>",
"    <p>",
"     Treatments to prevent cryptococcosis are not recommended because this has not been shown to improve survival.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      COCCIDIOIDES",
"     </span>",
"    </p>",
"    <p>",
"     Coccidioides is a fungus that can cause an infection, called coccidioidomycosis (pronounced cox-SID-ee-oh-doe-my-coe-sis). The most common type of coccidioidomycosis is a type of pneumonia known as Valley Fever. People who are infected with HIV are at risk for a serious bodywide coccidioidomycosis infection, known as disseminated coccidioidomycosis.",
"    </p>",
"    <p>",
"     The majority of cases of coccidioidomycosis in the United States occur in the southwestern part of the country, primarily Arizona and California. The fungus is normally found in the soil, and most people become infected after inhaling spores of the fungus.",
"    </p>",
"    <p>",
"     Treatments to prevent infection with Coccidioides are not usually recommended because this has not been shown to improve survival. However, people with HIV who live in areas where the fungus is common are advised to stay indoors during dust storms and to avoid activities that could expose them to dust or desert soil (eg, construction work, farming, gardening).",
"    </p>",
"    <p>",
"     People who are HIV-positive who become infected with Coccidioides are generally treated as soon as possible with an antifungal medication; this can reduce the risk of developing serious complications.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H9\">",
"     <span class=\"h1\">",
"      CYTOMEGALOVIRUS",
"     </span>",
"    </p>",
"    <p>",
"     Cytomegalovirus (CMV) is a virus that commonly causes infection in persons worldwide. CMV can lead to a mild illness with fever and body aches, but most of the time, this infection does not cause any symptoms.",
"    </p>",
"    <p>",
"     However, CMV persists in the body and in a patient with AIDS, CMV can lead to disease in the eyes, digestive system, brain and spinal cord. Infection of the eye (retina) is the most common opportunistic CMV infection and can cause blurring of vision, a progressive loss of vision, and even blindness in patients with AIDS.",
"    </p>",
"    <p>",
"     Past exposure to CMV infection is common, with approximately 50 percent of the adults in the United States having been exposed at some point during their life. If a blood test in an HIV-infected patient demonstrates past infection, a routine eye examination will be done to look at the retina in patients with T cell counts less than 250 cells, whether or not they have any eye symptoms. &nbsp;",
"    </p>",
"    <p>",
"     Treatment to prevent infection with CMV is not usually recommended because this has not been shown to improve survival. However, anyone with early signs of CMV retinitis (eg, blurry vision, blind spots, flashing lights, or floaters) should contact their healthcare provider immediately because treatment for this condition is very effective if given promptly.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h1\">",
"      CRYPTOSPORIDIUM",
"     </span>",
"    </p>",
"    <p>",
"     Cryptosporidium (pronounced crip-toe-spore-ID-ee-um) is a parasite that can infect people who consume contaminated drinking and swimming water. The parasite can also be spread through contact with feces from infected pets or humans. Infection with the parasite is called cryptosporidiosis, and is a common cause of diarrhea in people with HIV.",
"    </p>",
"    <p>",
"     All people are susceptible to infection, but HIV-infected persons with T counts less than 100",
"     <span class=\"nowrap\">",
"      cells/microL",
"     </span>",
"     can have an unusually severe and prolonged illness. To reduce the risk of infection, HIV infected people should wash hands after diaper changing or contact with pets or soil. Avoid close contact with people who are infected with cryptosporidium. During outbreaks that are thought to be related to contamination of the municipal water supply, drinking bottled water or boiling tap water can reduce the risk of becoming infected.",
"    </p>",
"    <p>",
"     There is no proven preventive treatment for Cryptosporidium. However, the preventive antibiotics used for Mycobacterium avium complex (MAC) may protect against cryptosporidial infection. Symptoms of infection usually resolve when T cells are boosted with HIV medications.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h1\">",
"      SUMMARY",
"     </span>",
"    </p>",
"    <p>",
"     Treatments to prevent opportunistic infections are recommended for some people with HIV, especially when the T cell count is low. The risk of each infection varies by the T cell count.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Preventive treatment recommended",
"     </span>",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       HIV-infected people with a T cell count &lt;200",
"       <span class=\"nowrap\">",
"        cells/microL",
"       </span>",
"       are at risk for developing pneumocystis infection. HIV-infected people with a T cell count &lt;100",
"       <span class=\"nowrap\">",
"        cells/microL",
"       </span>",
"       who have a positive blood test for Toxoplasma are at risk for reactivation of this infection. HIV-infected people with a T cell count &lt;150",
"       <span class=\"nowrap\">",
"        cells/microL",
"       </span>",
"       who live in areas with a large number of cases of histoplasmosis. HIV-infected people with a T cell count &lt;50",
"       <span class=\"nowrap\">",
"        cells/microL",
"       </span>",
"       are at risk for MAC infections",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Discontinuation of preventive treatment",
"     </span>",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Preventive treatment for mycobacterium avium complex is usually discontinued when the T cell count is &gt;100",
"       <span class=\"nowrap\">",
"        cells/microL",
"       </span>",
"       for 3 months.",
"      </li>",
"      <li>",
"       Preventive treatment for pneumocystis and toxoplasmosis is usually discontinued when the T cell count is &gt;200",
"       <span class=\"nowrap\">",
"        cells/microL",
"       </span>",
"       for 3 months.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H14\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3498566821\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15455293\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?21/25/21907?source=see_link\">",
"      Patient information: HIV/AIDS (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/41/36498?source=see_link\">",
"      Patient information: Vaccines for people with HIV (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?7/24/7554?source=see_link\">",
"      Patient information: Pneumocystis pneumonia (PCP) (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15455301\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?15/31/15861?source=see_link\">",
"      Patient information: Initial treatment of HIV (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/56/2946?source=see_link\">",
"      Patient information: Tips for taking HIV medications (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/53/2899?source=see_link\">",
"      Patient information: Vaginal yeast infection (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/43/20154?source=see_link\">",
"      Approach to the HIV-infected patient with pulmonary symptoms",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/8/13449?source=see_link\">",
"      Cryptococcal infection outside the central nervous system",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/6/9321?source=see_link\">",
"      Diagnosis and treatment of disseminated histoplasmosis in non-HIV-infected patients",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/23/21881?source=see_link\">",
"      Diagnosis and treatment of pulmonary histoplasmosis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/35/23098?source=see_link\">",
"      Immune reconstitution inflammatory syndrome",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/55/38777?source=see_link\">",
"      Mycobacterium avium complex (MAC) infections in HIV-infected patients",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/5/42071?source=see_link\">",
"      Overview of Candida infections",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/42/33450?source=see_link\">",
"      Primary prevention of opportunistic infections in HIV-infected patients",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/22/33129?source=see_link\">",
"      Toxoplasmosis in HIV-infected patients",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/1/13337?source=see_link\">",
"      Treatment of AIDS-related cytomegalovirus retinitis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/60/27593?source=see_link\">",
"      Treatment of Pneumocystis infection in HIV-infected patients",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Centers for Disease Control and Prevention (CDC)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; Toll-free: (800) 311-3435",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cdc.gov/\">",
"      www.cdc.gov",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       CDC (Centers for Disease Control and Prevention) National AIDS Hotline",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;English: (800) 342-2437",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;Spanish: (800) 344-7432",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Allergy and Infectious Diseases (NIAID)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.niaid.nih.gov/\">",
"      www.niaid.nih.gov",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       <span class=\"nowrap\">",
"        HIV/AIDS",
"       </span>",
"       Treatment Information Service",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;Toll-free: (800) 448-0440",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.hivatis.org/\">",
"      www.hivatis.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       AIDS Clinical Trials Information Service (ACTIS)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;Toll-free: (800) 874-2572",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.actis.org/\">",
"      www.actis.org",
"     </a>",
"     )",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h2\">",
"      Patient support",
"     </span>",
"     &nbsp;&mdash;&nbsp;There are a number of online forums where patients can find information and support from other people with similar conditions.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       <a class=\"external\" href=\"file://about.com/\">",
"        About.com",
"       </a>",
"       <span class=\"nowrap\">",
"        HIV/AIDS",
"       </span>",
"       Forum",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://aids.about.com/forum\">",
"      file://aids.about.com/forum",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?43/39/44658/abstract/1-3\">",
"      1-3",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 8, 2010.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?43/39/44658?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44658/abstract/1\">",
"      Kaplan JE, Masur H, Holmes KK, et al. Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 2002; 51:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44658/abstract/2\">",
"      Kovacs JA, Masur H. Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection. N Engl J Med 2000; 342:1416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44658/abstract/3\">",
"      Benson CA, Kaplan JE, Masur H, et al. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Recomm Rep 2004; 53:1.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f43_39_44658=[""].join("\n");
var outline_f43_39_44658=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           INTRODUCTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           PNEUMOCYSTIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           TOXOPLASMA",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H4\">",
"           MYCOBACTERIUM AVIUM COMPLEX (MAC)",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H5\">",
"           HISTOPLASMOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           CANDIDA (YEAST)",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H7\">",
"           CRYPTOCOCCUS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H8\">",
"           COCCIDIOIDES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H9\">",
"           CYTOMEGALOVIRUS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H10\">",
"           CRYPTOSPORIDIUM",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11\">",
"           SUMMARY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H14\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f43_39_44659="Antihypertensive drugs and lipids";
var content_f43_39_44659=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Antihypertensive drugs and lipids",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/39/44659/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/39/44659/contributors\">",
"     Norman M Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/39/44659/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/39/44659/contributors\">",
"     George L Bakris, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/39/44659/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/39/44659/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/39/44659/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 5, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early trials on the treatment of hypertension based upon high doses of diuretics or beta-blockers demonstrated a significant reduction in stroke but a less prominent decline in the incidence of coronary heart disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/1\">",
"     1",
"    </a>",
"    ]. This relative lack of coronary benefit may have been related to the adverse effect of these antihypertensive agents on plasma lipids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/2\">",
"     2",
"    </a>",
"    ], since even small elevations in serum cholesterol may significantly increase coronary risk, particularly in patients with underlying hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/3\">",
"     3",
"    </a>",
"    ]. However, when another analysis was published in 2003, which included multiple studies with lower doses of diuretics and newer agents, a greater reduction of coronary heart disease was documented [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Drug-induced changes in lipid levels may be particularly important in hypertensives, since up to 40 percent of untreated patients with primary hypertension (formerly called &ldquo;essential&rdquo; hypertension) already have lipid abnormalities, such as a high LDL-cholesterol and a low HDL-cholesterol [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/5\">",
"     5",
"    </a>",
"    ]. Obesity, diabetes, or alcohol abuse may be responsible for this association. In addition, genetic studies in humans suggest that a predisposition for the development of both hypertension and dyslipidemia may result from the inheritance of shared genetic risk factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/40/44677?source=see_link\">",
"     \"Prehypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is important to appreciate, however, that the potential adverse effect of antihypertensive therapy on lipid metabolism does not mean that such therapy should be withheld. A report from the Helsinki Heart Study, for example, demonstrated that effectively treating hypertension in hypertensive, dyslipidemic men (primarily with diuretics and &szlig;-blockers) reduced the risk of coronary events by more than 50 percent when compared to those with persistent hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Treatment of dyslipidemia with HMG CoA reductase inhibitors (statins) may independently lower BP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. This was best shown by the UCSD Statin study, which was a randomized placebo-controlled trial that included 973 subjects and examined the effect of either 20 mg of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/36/17993?source=see_link\">",
"     simvastatin",
"    </a>",
"    , 40 mg of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/27/25016?source=see_link\">",
"     pravastatin",
"    </a>",
"    or placebo on blood pressure at six months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/10\">",
"     10",
"    </a>",
"    ]. Both statins modestly reduced systolic and diastolic blood pressure by 2.2 and 2.4, respectively. Given that the beneficial actions of antihypertensive agents and statins are not adversely affected (and may be enhanced) with concurrent use, hypertension and dyslipidemia can be effectively treated by administering both classes of drugs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EFFECTS OF DIFFERENT ANTIHYPERTENSIVE AGENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effects of the different classes of antihypertensive drugs on plasma lipid levels can be summarized as follows:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Thiazide diuretics",
"    </span>",
"    &nbsp;&mdash;&nbsp;High doses (50",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    or more) of thiazide diuretics produce an initial five to 10 percent elevation in total and LDL-cholesterol and a lesser increase in triglycerides. Some long-term studies have shown that the cholesterol levels return to normal after one year.",
"   </p>",
"   <p>",
"    The hyperlipidemic effect of thiazide diuretics is dose-dependent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/2\">",
"     2",
"    </a>",
"    ]. There is, for example, little or no effect on lipid metabolism with a daily dose of 12.5 mg of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/4/8263?source=see_link\">",
"     hydrochlorothiazide",
"    </a>",
"    or its equivalent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/11\">",
"     11",
"    </a>",
"    ], a dose which may have as great an antihypertensive effect as higher doses (",
"    <a class=\"graphic graphic_figure graphicRef61248 \" href=\"mobipreview.htm?18/24/18829\">",
"     figure 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/63/15350?source=see_link\">",
"     \"Use of thiazide diuretics in patients with primary hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Beta blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effect of beta blockers on serum lipids varies with their pharmacologic characteristics, and may be more prominent among smokers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/2,12\">",
"     2,12",
"    </a>",
"    ]. Nonselective and beta-1-selective beta blockers have little effect on cholesterol levels but lead to an approximate 10 percent fall in cardioprotective HDL-cholesterol and, particularly with nonselective agents, a 20 to 40 percent rise in triglycerides [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/2\">",
"     2",
"    </a>",
"    ]. In contrast, lipid levels are relatively unaffected by",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/45/35544?source=see_link\">",
"     labetalol",
"    </a>",
"    (a combined alpha- and beta-blocker) and beta blockers with intrinsic sympathomimetic activity (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/11/37047?source=see_link\">",
"     acebutolol",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/15/10487?source=see_link\">",
"     pindolol",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Newer vasodilating beta blockers have a more favorable metabolic profile;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/22/9577?source=see_link\">",
"     carvedilol",
"    </a>",
"    , a combined nonselective beta and alpha-1 blocker, also prevents lipid peroxidation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. As an example, one study evaluated 45 patients with non-insulin-dependent diabetes mellitus and hypertension who were randomly assigned to therapy with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39417?source=see_link\">",
"     metoprolol",
"    </a>",
"    or carvedilol [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/14\">",
"     14",
"    </a>",
"    ]. Carvedilol was associated with a significantly greater fall in total cholesterol and lesser rise in triglycerides than metoprolol. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/38/12905?source=see_link\">",
"     \"Use of beta blockers in heart failure due to systolic dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Alpha-blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The selective alpha-1 blockers,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/16/23814?source=see_link\">",
"     prazosin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/59/8119?source=see_link\">",
"     doxazosin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/15/36085?source=see_link\">",
"     terazosin",
"    </a>",
"    , represent another class of antihypertensive agents that has a favorable effect on plasma lipids, lowering total cholesterol by about 3 to 5 percent, reducing triglyceride levels by 3 to 4 percent, and mildly raising HDL-cholesterol [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/2,15\">",
"     2,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Sympathetic blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effect of the centrally acting sympathetic inhibitors,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/15/28918?source=see_link\">",
"     methyldopa",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/53/19289?source=see_link\">",
"     clonidine",
"    </a>",
"    , and guanabenz, on the lipid profile has not been well studied, as both favorable and detrimental changes have been reported. On average, there is little if any change in lipid levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Angiotensin converting enzyme inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ACE inhibitors appear to have no important effect on plasma lipids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/2\">",
"     2",
"    </a>",
"    ] and may minimize or prevent the rise in lipids induced by diuretic therapy (via an unknown mechanism) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Calcium channel blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The calcium channel blockers appear to have either a neutral or mildly beneficial effect on the lipid profile [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Combination therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effect of combination therapy in most cases appears to reflect the sum of the effect of the individual drugs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Solely viewed from the viewpoint of plasma lipids, an alpha-blocker, ACE inhibitor, or calcium channel blocker may be the preferred initial therapy in a patient with underlying hyperlipidemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As noted above, however, administration of low doses of thiazide diuretics",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    &szlig;-blockers to dyslipidemic hypertensive men substantially reduces the incidence of coronary events if the blood pressure was well controlled [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44659/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44659/abstract/1\">",
"      Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997; 277:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44659/abstract/2\">",
"      Kasiske BL, Ma JZ, Kalil RS, Louis TA. Effects of antihypertensive therapy on serum lipids. Ann Intern Med 1995; 122:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44659/abstract/3\">",
"      McMahan CA, Gidding SS, Fayad ZA, et al. Risk scores predict atherosclerotic lesions in young people. Arch Intern Med 2005; 165:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44659/abstract/4\">",
"      Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003; 289:2534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44659/abstract/5\">",
"      Goode GK, Miller JP, Heagerty AM. Hyperlipidaemia, hypertension, and coronary heart disease. Lancet 1995; 345:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44659/abstract/6\">",
"      Williams RR, Hunt SC, Hopkins PN, et al. Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA 1988; 259:3579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44659/abstract/7\">",
"      M&auml;ntt&auml;ri M, Tenkanen L, Manninen V, et al. Antihypertensive therapy in dyslipidemic men. Effects on coronary heart disease incidence and total mortality. Hypertension 1995; 25:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44659/abstract/8\">",
"      Sp&oacute;sito AC, Mansur AP, Coelho OR, et al. Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril). Am J Cardiol 1999; 83:1497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44659/abstract/9\">",
"      Tonolo G, Melis MG, Formato M, et al. Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients. Eur J Clin Invest 2000; 30:980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44659/abstract/10\">",
"      Golomb BA, Dimsdale JE, White HL, et al. Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial. Arch Intern Med 2008; 168:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44659/abstract/11\">",
"      Reaven GM, Clinkingbeard C, Jeppesen J, et al. Comparison of the hemodynamic and metabolic effects of low-dose hydrochlorothiazide and lisinopril treatment in obese patients with high blood pressure. Am J Hypertens 1995; 8:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44659/abstract/12\">",
"      Vyssoulis GP, Karpanou EA, Pitsavos CE, et al. Dyslipidemic effects of cigarette smoking on beta-blocker-induced serum lipid changes in systemic hypertension. Am J Cardiol 1991; 67:987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44659/abstract/13\">",
"      Giugliano D, Acampora R, Marfella R, et al. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial. Ann Intern Med 1997; 126:955.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44659/abstract/14\">",
"      Bakris GL, Fonseca V, Katholi RE, et al. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA 2004; 292:2227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44659/abstract/15\">",
"      Levy D, Walmsley P, Levenstein M. Principal results of the Hypertension and Lipid Trial (HALT): a multicenter study of doxazosin in patients with hypertension. Am Heart J 1996; 131:966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44659/abstract/16\">",
"      Weinberger MH. Influence of an angiotensin converting-enzyme inhibitor on diuretic-induced metabolic effects in hypertension. Hypertension 1983; 5:III132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44659/abstract/17\">",
"      Kannel WB, Carter BL. Initial drug therapy for hypertensive patients with hyperlipidemia. Am Heart J 1989; 118:1012.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3867 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-89.32.226.102-D86B8ADF8C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_39_44659=[""].join("\n");
var outline_f43_39_44659=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EFFECTS OF DIFFERENT ANTIHYPERTENSIVE AGENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Thiazide diuretics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Beta blockers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Alpha-blockers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Sympathetic blockers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Angiotensin converting enzyme inhibitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Calcium channel blockers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Combination therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/3867\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/3867|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?18/24/18829\" title=\"figure 1\">",
"      Antihypertensive dose-response to thiazide therapy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/40/44677?source=related_link\">",
"      Prehypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/38/12905?source=related_link\">",
"      Use of beta blockers in heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/63/15350?source=related_link\">",
"      Use of thiazide diuretics in patients with primary hypertension",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_39_44660="Magaldrate and simethicone: Drug information";
var content_f43_39_44660=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Magaldrate and simethicone: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?9/37/9812?source=see_link\">",
"    see \"Magaldrate and simethicone: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F190726\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antacid;",
"     </li>",
"     <li>",
"      Antiflatulent",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F190717\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Hyperacidity/gas:",
"     </b>",
"     Oral: 5-10 mL (540-1080 mg magaldrate) between meals and at bedtime",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F190718\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F190708\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suspension, oral: Magaldrate 540 mg and simethicone 20 mg per 5 mL (360 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F190697\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F9526031\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer on empty stomach.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F190710\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Relief of hyperacidity associated with peptic ulcer, gastritis, peptic esophagitis, and hiatal hernia which are accompanied by symptoms of gas",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F190730\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Riopan Plus&reg; may be confused with Repan&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F190724\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Based on",
"     <b>",
"      magaldrate",
"     </b>",
"     component:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Encephalopathy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Constipation, chalky taste, stomach cramps, fecal impaction, diarrhea, nausea, vomiting, discoloration of feces (white speckles), rebound hyperacidity",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hypophosphatemia, hypermagnesemia, milk-alkali syndrome",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; metabolic: Osteomalacia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Aluminum intoxication",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Based on",
"     <b>",
"      simethicone",
"     </b>",
"     component: No data reported",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F190712\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Based on",
"     <b>",
"      magaldrate",
"     </b>",
"     component: Hypersensitivity to magaldrate or any component of the formulation; patients with colostomy or an ileostomy; appendicitis; ulcerative colitis; diverticulitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Based on",
"     <b>",
"      simethicone",
"     </b>",
"     component: Hypersensitivity to simethicone or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299627\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F190703\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACE Inhibitors: Antacids may decrease the serum concentration of ACE Inhibitors.  Management: Separate fosinopril administration from antacids by at least 2 hours. US and Canadian recommendations for use of other ACE- inhibitors with antacids may vary. Consult appropriate labeling. Monitor for decreased therapeutic effects of ACE-inhibitors.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Enalaprilat; Ramipril.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Allopurinol: Antacids may decrease the absorption of Allopurinol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha-/Beta-Agonists: Antacids may decrease the excretion of Alpha-/Beta-Agonists.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dipivefrin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: Antacids may decrease the excretion of Amphetamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticonvulsants (Hydantoin): Antacids may decrease the serum concentration of Anticonvulsants (Hydantoin).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotic Agents (Phenothiazines): Antacids may decrease the absorption of Antipsychotic Agents (Phenothiazines).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Atazanavir: Antacids may decrease the absorption of Atazanavir.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bisacodyl: Antacids may diminish the therapeutic effect of Bisacodyl. Antacids may cause the delayed-release bisacodyl tablets to release drug prior to reaching the large intestine.  Gastric irritation and/or cramps may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: Antacids may decrease the serum concentration of Bosutinib.  Management: Administer antacids more than 2 hours before or after bosutinib.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Polystyrene Sulfonate: Antacids may enhance the adverse/toxic effect of Calcium Polystyrene Sulfonate. The combined use of these two agents may result in metabolic alkalosis and/or loss of efficacy of the cation exchange resin.  Management: To minimize this interaction, consider: a)separating doses by 2 or more hours; b)rectal administration of the exchange resin; or c)alternatives to antacids. Monitor for metabolic alkalosis and attenuation of CPS effects. Avoid magnesium hydroxide.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cefditoren: Antacids may decrease the serum concentration of Cefditoren.  Management: Concomitant use of cefditoren with antacids is not recommended. Consider alternative methods to control acid reflux (eg, diet modification) or alternative antimicrobial therapy. If antacid therapy can not be avoided, separate dosing by several hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cefpodoxime: Antacids may decrease the serum concentration of Cefpodoxime.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cefuroxime: Antacids may decrease the serum concentration of Cefuroxime.  Management:  Consider administering antacids and cefuroxime at least 2 hours apart.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Chloroquine: Antacids may decrease the serum concentration of Chloroquine.  Management: Separate administration of antacids and chloroquine by at least 4 hours to minimize any potential negative impact of antacids on chloroquine bioavailability.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Oral): Antacids may decrease the bioavailability of Corticosteroids (Oral).  Management: Consider separating doses by 2 or more hours. Budesonide enteric coated tablets could dissolve prematurely if given with drugs that lower gastric acid, with unknown impact on budesonide therapeutic effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: Antacids may decrease the serum concentration of Dabigatran Etexilate.  Management: Dabigatran etexilate Canadian product labeling recommends avoiding concomitant use with antacids for 24 hours after surgery. In other situations, administer dabigatran etexilate 2 hours prior to antacids. Monitor clinical response to dabigatran therapy.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: Antacids may decrease the absorption of Dasatinib.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferiprone: Antacids may decrease the serum concentration of Deferiprone.  Management: Separate administration of deferiprone and oral medications or supplements that contain polyvalent cations by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Delavirdine: Antacids may decrease the serum concentration of Delavirdine.  Management: Separate doses of delavirdine and antacids by at least 1 hour. Monitor for decreased delavirdine therapeutic effects with this combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dexmethylphenidate: Antacids may increase the absorption of Dexmethylphenidate. Specifically, antacids may interfere with the normal release of drug from the extended-release capsules (Focalin XR brand), which could result in both increased absorption (early) and decreased delayed absorption.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Elvitegravir: Antacids may decrease the serum concentration of Elvitegravir.  Management: Separate administration of antacids and the elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate combination product by at least 2 hours in order to minimize the risk for an interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Erlotinib: Antacids may decrease the serum concentration of Erlotinib.  Management: Separate the administration of erlotinib and any antacid by several hours in order to minimize the risk of a significant interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gabapentin: Antacids may decrease the serum concentration of Gabapentin.  Management: Administer gabapentin at least 2 hours after antacid administration.  Monitor patients closely for evidence of reduced response to gabapentin therapy when both of these drugs are being used.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HMG-CoA Reductase Inhibitors: Antacids may decrease the serum concentration of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iron Salts: Antacids may decrease the absorption of Iron Salts.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Ferric Gluconate; Ferumoxytol; Iron Dextran Complex; Iron Sucrose.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Isoniazid: Antacids may decrease the absorption of Isoniazid.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Itraconazole: Antacids may decrease the serum concentration of Itraconazole.  Management: Administer itraconazole at least 1 hour after and 2 hours before administration of any antacids.  Itraconazole oral suspension may be less sensitive to the effects of decreased gastric acidity.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketoconazole (Systemic): Antacids may decrease the serum concentration of Ketoconazole (Systemic).  Management: Administer oral ketoconazole at least 2 hours prior to use of any antacid product.  Monitor patients closely for signs of inadequate clinical response to ketoconazole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mesalamine: Antacids may diminish the therapeutic effect of Mesalamine. Antacid-mediated increases in gastrointestinal pH may cause the premature release of mesalamine from specific sustained-release mesalamine products.  Management: Avoid concurrent administration of antacids with sustained-release mesalamine products.  Separating antacid and mesalamine administration, and/or using lower antacid doses may be adequate means of avoiding this interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methenamine: Antacids may diminish the therapeutic effect of Methenamine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: Antacids may increase the absorption of Methylphenidate. Specifically, antacids may interfere with the normal release of drug from the extended-release capsules (Ritalin LA brand), which could result in both increased absorption (early) and decreased delayed absorption.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Misoprostol: Antacids may enhance the adverse/toxic effect of Misoprostol. More specifically, concomitant use with magnesium-containing antacids may increase the risk of diarrhea.  Management: Avoid concomitant use of misoprostol and magnesium-containing antacids. In patients requiring antacid therapy, employ magnesium-free preparations. Monitor for increased adverse effects (e.g., diarrhea, dehydration).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): Antacids may decrease the serum concentration of Multivitamins/Minerals (with ADEK, Folate, Iron). Specifically, antacids may decrease the absorption of orally administered iron.  Management: Separate dosing of oral iron-containing multivitamin preparations and antacids by as much time as possible in order to minimize impact on therapeutic efficacy of the iron preparation.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mycophenolate: Antacids may decrease the absorption of Mycophenolate.  Management: Separate doses of mycophenolate and antacids by at least 2 hours. Monitor for reduced effects of mycophenolate if taken concomitant with antacids.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nilotinib: Antacids may decrease the serum concentration of Nilotinib.  Management: Separate the administration of nilotinib and any antacid by several hours whenever possible in order to minimize the risk of a significant interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     PenicillAMINE: Antacids may decrease the serum concentration of PenicillAMINE.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphate Supplements: Antacids may decrease the absorption of Phosphate Supplements.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Potassium Phosphate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ponatinib: Antacids may decrease the serum concentration of Ponatinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protease Inhibitors: Antacids may decrease the absorption of Protease Inhibitors.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Darunavir.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: Antacids may decrease the excretion of QuiNIDine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNINE: Antacids may decrease the serum concentration of QuiNINE.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinolone Antibiotics: Antacids may decrease the absorption of Quinolone Antibiotics. Of concern only with oral administration of quinolones.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rilpivirine: Antacids may decrease the serum concentration of Rilpivirine.  Management: Administer antacids at least 2 hours before or 4 hours after rilpivirine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Polystyrene Sulfonate: Antacids may enhance the adverse/toxic effect of Sodium Polystyrene Sulfonate. The combined use of these two agents may result in metabolic alkalosis and/or loss of efficacy of the exchange resin.  Management: To minimize this interaction, consider: a)separating doses by 2 or more hours; b)rectal administration of the exchange resin; or c)alternatives to antacids. Monitor for metabolic alkalosis and attenuation of SPS effects. Avoid magnesium hydroxide.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetracycline Derivatives: Antacids may decrease the absorption of Tetracycline Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trientine: Antacids may decrease the absorption of Trientine.  Management: Separate trientine dosing from other oral drugs (eg, antacids) by at least 1 hour. Monitor for decreased therapeutic effects of trientine if an antacid is initiated/dose increased, or increased effects if an antacid is discontinued/dose decreased.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vismodegib: Antacids may decrease the serum concentration of Vismodegib.  Management: Carefully consider the need for any medication that increases the pH of the upper GI tract (PPIs, H2RAs, antacids), as these could significantly reduce vismodegib systemic exposure. Vismodegib dose increases are unlikely to compensate for this effect.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F190713\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Should be taken on empty stomach.",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F13276678\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Digeril (EC);",
"     </li>",
"     <li>",
"      Tiamacon (TW)",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10120 Version 40.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-2332FC6495-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_39_44660=[""].join("\n");
var outline_f43_39_44660=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190726\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190717\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190718\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190708\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190697\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9526031\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190710\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190730\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190724\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190712\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299627\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190703\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190713\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13276678\">",
"      International Brand Names",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10120\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10120|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?9/37/9812?source=related_link\">",
"      Magaldrate and simethicone: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_39_44661="Interstitial edema PA";
var content_f43_39_44661=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F58231&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F58231&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left ventricular failure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 336px; height: 338px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph shows cephalization of pulmonary vascular flow with interstitial edema and conspicuous septal lines.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_39_44661=[""].join("\n");
var outline_f43_39_44661=null;
var title_f43_39_44662="Clinical manifestations and evaluation of bronchiectasis in children";
var content_f43_39_44662=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and evaluation of bronchiectasis in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/39/44662/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/39/44662/contributors\">",
"     Khoulood Fakhoury, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/39/44662/contributors\">",
"     Adaobi Kanu, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/39/44662/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/39/44662/contributors\">",
"     George B Mallory, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/39/44662/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/39/44662/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/39/44662/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 8, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchiectasis is a structural abnormality characterized by abnormal dilation and distortion of the bronchial tree, resulting in chronic obstructive lung disease. This condition is typically the end result of a variety of pathophysiologic processes that render the bronchial walls weakened, easily collapsible, chronically inflamed, and plugged with mucus secretions. Associated findings include atelectasis, emphysema, fibrosis, and hypertrophy of the bronchial vasculature.",
"   </p>",
"   <p>",
"    In developed nations, cystic fibrosis (CF) is the most common cause of bronchiectasis in children. The evaluation of CF-related bronchiectasis is presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/49/28442?source=see_link\">",
"     \"Cystic fibrosis: Clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/45/27351?source=see_link\">",
"     \"Cystic fibrosis: Clinical manifestations of pulmonary disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bronchiectasis can be caused by a variety of disease processes other than CF, most of which include some combination of bronchial obstruction and infection. The types of disorders that cause bronchiectasis vary among populations and age groups. Infections and acquired causes of bronchiectasis are more common in adults and in developing nations, whereas congenital anomalies of the bronchi or immune system are more prominent in children and in industrialized nations.",
"   </p>",
"   <p>",
"    This topic review will outline the clinical manifestations and evaluation of non-CF-related bronchiectasis in children. The causes and management of non-CF-related bronchiectasis in children, and the clinical manifestations and diagnosis of bronchiectasis in adults are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/43/16057?source=see_link\">",
"     \"Causes of bronchiectasis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/0/6150?source=see_link\">",
"     \"Management of bronchiectasis in children without cystic fibrosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/10/12458?source=see_link\">",
"     \"Clinical manifestations and diagnosis of bronchiectasis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common symptom in children with bronchiectasis is persistent cough, which is present in 80 to 90 percent of pediatric patients with bronchiectasis, and is typically \"wet\" or productive [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44662/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Fifty-seven to 74 percent of children also produce purulent sputum. The absence of sputum production does not exclude bronchiectasis because young children may not be able to expectorate sputum.",
"   </p>",
"   <p>",
"    Some patients present with episodic exacerbations of infection, characterized by increased cough and sputum production that may be associated with fever, pleuritic chest pain, and dyspnea. These exacerbations typically respond to antibiotic therapies.",
"   </p>",
"   <p>",
"    Although hemoptysis is common in adults, it is uncommon in children, reported in only 4 to 7 percent of those with bronchiectasis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44662/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Hemoptysis is caused by erosion of inflamed airway tissue adjacent to pulmonary vessels. The amount of bleeding can range from mild, with blood streaked sputum, to profuse amounts of fresh blood if the systemic bronchial vessels are eroded.",
"   </p>",
"   <p>",
"    Dyspnea and exercise intolerance are uncommon at presentation but may develop as the disease progresses, or may occur during an acute exacerbation of the disease due to intercurrent infection. Children with severe bronchiectatic lung disease may have cyanosis, indicating severe hypoxemia due to mismatched pulmonary ventilation and perfusion. If the hypoxemia is prolonged and profound, it may lead to pulmonary hypertension and cor pulmonale.",
"   </p>",
"   <p>",
"    Other symptoms related to the underlying cause for bronchiectasis may be seen at presentation. For example, failure to thrive is frequently seen in diseases such as cystic fibrosis (CF) and immunodeficiency disorders. Chronic sinusitis is common among children with CF, ciliary dysfunction disorders, and immunodeficiencies. Chronic ear infection with or without otorrhea is an additional characteristic of ciliary dysfunction. The presence of congenital anomalies should alert the clinician to the possibility of associated anomalies that predispose to bronchiectasis (eg, congenital heart disease and anomalies of the tracheobronchial tree in the VACTERL association). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/43/16057?source=see_link&amp;anchor=H4#H4\">",
"     \"Causes of bronchiectasis in children\", section on 'Causes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goals of the evaluation are to confirm the diagnosis of bronchiectasis, identify the underlying etiology and any potentially treatable causes, and to assess the severity of pulmonary disease.",
"   </p>",
"   <p>",
"    A variety of underlying disease processes can cause bronchiectasis; the cause should be determined whenever possible because this may direct treatment (",
"    <a class=\"graphic graphic_table graphicRef87712 \" href=\"mobipreview.htm?26/62/27630\">",
"     table 1",
"    </a>",
"    ). In a minority of pediatric cases, an underlying cause cannot be identified despite a thorough evaluation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/43/16057?source=see_link\">",
"     \"Causes of bronchiectasis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The evaluation includes a complete medical history and physical examination, as well as laboratory testing, radiographic imaging, and pulmonary function testing in older children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Medical history",
"    </span>",
"    &nbsp;&mdash;&nbsp;A complete medical history, including past medical, family, travel, and environmental history, is a crucial part of the evaluation and can be helpful in identifying the underlying cause for bronchiectasis. Certain features of the history should raise concern for specific underlying disorders:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Failure to thrive &mdash; Suggests CF or immunodeficiencies. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/49/28442?source=see_link\">",
"       \"Cystic fibrosis: Clinical manifestations and diagnosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/47/30458?source=see_link\">",
"       \"Approach to the child with recurrent infections\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/48/24326?source=see_link\">",
"       \"Primary humoral immune deficiencies: An overview\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Steatorrhea &mdash; Suggests CF.",
"     </li>",
"     <li>",
"      Sinopulmonary disease &mdash; Suggests CF, primary ciliary dyskinesia, or immunodeficiency. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/37/9817?source=see_link\">",
"       \"Primary ciliary dyskinesia (immotile-cilia syndrome)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      History of choking &mdash; Suggests foreign body aspiration, or a swallowing disorder with chronic aspiration of oropharyngeal contents. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/33/2585?source=see_link\">",
"       \"Airway foreign bodies in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Neurologic disease or swallowing dysfunction &mdash; Suggests aspiration. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/46/38632?source=see_link\">",
"       \"Aspiration due to swallowing dysfunction in infants and children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/41/41625?source=see_link&amp;anchor=H22#H22\">",
"       \"Clinical manifestations and diagnosis of gastroesophageal reflux disease in children and adolescents\", section on 'Recurrent pneumonia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Congenital anomalies (especially cardiac or renal disease) &mdash; Suggests associated congenital anomalies of the tracheobronchial tree, as in the VACTERL association. Dextrocardia suggests primary ciliary dyskinesia. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/27/29114?source=see_link\">",
"       \"Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The history is also helpful in assessing the duration of symptoms, progression over time and severity of the disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The general physical examination may also identify the features described above that point to an underlying etiology, including failure to thrive, sinus and ear infections, neurologic dysfunction, or the presence of congenital anomalies.",
"   </p>",
"   <p>",
"    Specific findings related to pulmonary disease and chronic infection include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Crackles (inspiratory popping sounds) and rhonchi (coarse expiratory breath sounds), which are often heard over the area of bronchiectasis",
"     </li>",
"     <li>",
"      Wheezing is less common; it is reported in 7 to 11 percent of children with bronchiectasis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44662/abstract/1,2\">",
"       1,2",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Clubbing of the nailbed, reported in 44 to 51 percent of children with bronchiectasis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44662/abstract/1-3\">",
"       1-3",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Chest wall deformity, which can be seen in obstructive lung diseases (eg, cystic fibrosis), in which hyperinflation of the lungs results in increased anterior to posterior chest diameter",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Chest radiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Findings that are suspicious for bronchiectasis include linear atelectasis, dilated and thickened airways (ie, tram-tracking or parallel lines on longitudinal view, or ring shadows on cross section) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef56034 \" href=\"mobipreview.htm?14/19/14655\">",
"     image 1",
"    </a>",
"    ), and irregular peripheral opacities that represent mucopurulent plugs. Other findings may include loss of lung volume and peribronchial fibrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44662/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The distribution of bronchiectasis may provide a clue to the underlying disease. In patients with cystic fibrosis or tuberculosis, the radiographic abnormalities are often concentrated in the upper lobes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44662/abstract/5\">",
"     5",
"    </a>",
"    ], whereas centrally located bronchiectasis is characteristic of allergic bronchopulmonary aspergillosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44662/abstract/6\">",
"     6",
"    </a>",
"    ]. In patients with bronchopulmonary sequestration, bronchiectasis is usually unilateral and in a lower lobe (",
"    <a class=\"graphic graphic_table graphicRef71732 \" href=\"mobipreview.htm?11/39/11900\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44662/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/29/29144?source=see_link\">",
"     \"Bronchopulmonary sequestration\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Radiographic features that suggest a specific disorder include increased caliber of the trachea and central airways (congenital tracheobronchomegaly, Mounier-Kuhn syndrome) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44662/abstract/8,9\">",
"     8,9",
"    </a>",
"    ], or unilateral hyperlucent lung (Swyer James syndrome) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44662/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. A single focal area of bronchiectasis raises the possibility of an airway foreign body or congenital pulmonary defect. Recurrent atelectasis and progressive bronchiectasis in the right middle lobe or lingula suggest middle lobe syndrome, particularly in a patient with asthma. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/43/16057?source=see_link\">",
"     \"Causes of bronchiectasis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     HRCT",
"    </span>",
"    &nbsp;&mdash;&nbsp;High resolution computed tomography (HRCT) is the most sensitive imaging method to detect bronchiectasis, and should be performed when the chest radiograph is normal or nonspecific in a patient with clinically suspected bronchiectasis. The sensitivity of HRCT for detecting bronchiectasis ranges from 82 to 97 percent when compared to the gold standard of bronchography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44662/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis of bronchiectasis is made when the internal diameter of the airway is larger than the diameter of the adjacent artery",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bronchi, visualized within 1 cm of the pleural surface [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44662/abstract/13\">",
"     13",
"    </a>",
"    ]. Airway wall thickening (\"signet ring\" shadows) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef73028 \" href=\"mobipreview.htm?30/26/31137\">",
"     image 2",
"    </a>",
"    ) with or without air fluid levels, volume loss, mucus plugging, and air trapping can also seen on the CT scan [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44662/abstract/12,13\">",
"     12,13",
"    </a>",
"    ] (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef68555 \" href=\"mobipreview.htm?19/38/20079\">",
"     image 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/10/12458?source=see_link&amp;anchor=H19#H19\">",
"     \"Clinical manifestations and diagnosis of bronchiectasis in adults\", section on 'Computed tomography'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bronchiectasis is often thought to be irreversible. However, HRCT imaging has demonstrated resolution of cylindrical bronchiectasis in some cases in which a reversible underlying cause (mostly infection) was identified and treated (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/43/16057?source=see_link&amp;anchor=H3#H3\">",
"     \"Causes of bronchiectasis in children\", section on 'Pathophysiology'",
"    </a>",
"    ). In addition, the CT scan may be helpful in identifying the etiology for bronchiectasis, such as anatomical and congenital airway abnormalities, or extraluminal compression by a lymph node, mass or aberrant blood vessels.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Laboratory studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory studies are selected to establish the underlying cause of the bronchiectasis, as directed by the history and physical exam. The distribution of bronchiectasis as shown by imaging studies also may point to specific causes and guide the laboratory evaluation (",
"    <a class=\"graphic graphic_table graphicRef71732 \" href=\"mobipreview.htm?11/39/11900\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    For patients with diffuse bronchiectasis, the evaluation includes testing for cystic fibrosis, using sweat chloride,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    DNA testing. In addition, patients should be tested for immunodeficiency, including a complete blood count with differential, IgM, IgA and IgG, and a humoral panel (immune response to childhood vaccines, specifically anti-tetanus, anti-diphtheria, and anti-pneumococcal antibodies).",
"   </p>",
"   <p>",
"    Additional tests of immune function may be indicated depending on the history and types of recurrent infection. Ciliary dyskinesia should be considered in an individual with dextrocardia,",
"    <span class=\"nowrap\">",
"     chronic/recurrent",
"    </span>",
"    ear and sinopulmonary infections, especially if there is a history of neonatal respiratory symptoms (transient tachypnea of the newborn or wet lungs). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/43/16057?source=see_link\">",
"     \"Causes of bronchiectasis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/37/9817?source=see_link&amp;anchor=H26740088#H26740088\">",
"     \"Primary ciliary dyskinesia (immotile-cilia syndrome)\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Other tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a patient with asthma or cystic fibrosis and bronchiectasis, the possibility of allergic bronchopulmonary aspergillosis (ABPA) should be considered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44662/abstract/6\">",
"     6",
"    </a>",
"    ]. Chest CT scans in ABPA usually show central airway bronchiectasis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef64077 \" href=\"mobipreview.htm?3/38/3682\">",
"     image 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/48/33545?source=see_link&amp;anchor=H9#H9\">",
"     \"Allergic bronchopulmonary aspergillosis\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/48/33545?source=see_link&amp;anchor=H12#H12\">",
"     \"Allergic bronchopulmonary aspergillosis\", section on 'ABPA in cystic fibrosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Tuberculosis should be considered in patients with risk factors, such as HIV infection, contact with individuals who have been in prison, or in those living in or immigrating from endemic countries. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/4/23625?source=see_link\">",
"     \"Tuberculosis disease in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Recurrent pneumonia and bronchiectasis may be caused by aspiration due to inadequate airway protective mechanisms during swallowing or dysphagia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44662/abstract/14\">",
"     14",
"    </a>",
"    ]. This is more commonly seen in patients with neurologic dysfunction. In such patients, this possibility should be evaluated by videofluoroscopy (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/46/38632?source=see_link\">",
"     \"Aspiration due to swallowing dysfunction in infants and children\"",
"    </a>",
"    ). Additional testing for patients in whom recurrent aspiration is suspected may include pH monitoring, upper gastrointestinal endoscopy, and nuclear scintigraphy. However, none of these tests provide definitive evidence that gastroesophageal reflux is the cause of the recurrent pneumonia (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/41/41625?source=see_link&amp;anchor=H22#H22\">",
"     \"Clinical manifestations and diagnosis of gastroesophageal reflux disease in children and adolescents\", section on 'Recurrent pneumonia'",
"    </a>",
"    ). In children with normal neurologic status, a laryngeal cleft or H-type tracheoesophageal fistula (TEF) can also result in aspiration; if these abnormalities are suspected, rigid laryngoscopy and bronchoscopy should be performed to establish the diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/27/29114?source=see_link\">",
"     \"Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/42/37543?source=see_link&amp;anchor=H13#H13\">",
"     \"Congenital anomalies of the larynx\", section on 'Laryngeal clefts'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Flexible bronchoscopy and bronchoalveolar lavage can be performed to assess for mechanical airway obstruction and to remove mucus plugs or to obtain lower airway cultures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44662/abstract/15\">",
"     15",
"    </a>",
"    ]. If an airway foreign body is discovered, or if it is strongly suspected based on the history or imaging, a rigid bronchoscope should be used for foreign body removal. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/33/2585?source=see_link\">",
"     \"Airway foreign bodies in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pulmonary function testing (for older children) can be helpful to evaluate the severity of lung disease and is a useful tool to evaluate acute exacerbations and long-term progression of lung disease. Most patients with bronchiectasis have features of obstructive lung disease, indicated by low FEV1 and",
"    <span class=\"nowrap\">",
"     FEV1/FVC",
"    </span>",
"    ratio. If fibrosis and scarring are present, there may also be a component of restrictive lung disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/27/29112?source=see_link\">",
"     \"Overview of pulmonary function testing in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?21/43/22195?source=see_link\">",
"       \"Patient information: Coughing up blood (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/57/40850?source=see_link\">",
"       \"Patient information: Bronchiectasis in children (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bronchiectasis is characterized by abnormal dilation and distortion of the bronchial tree, resulting in chronic obstructive lung disease. This condition is the end result of a variety of pathophysiologic processes, usually a combination of infection and impaired airway drainage or obstruction. Important causes of bronchiectasis in children include cystic fibrosis, chronic aspiration, infection (with or without underlying immunodeficiency), foreign body aspiration, and congenital pulmonary defects (",
"      <a class=\"graphic graphic_table graphicRef87712 \" href=\"mobipreview.htm?26/62/27630\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/43/16057?source=see_link\">",
"       \"Causes of bronchiectasis in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The signs and symptoms of bronchiectasis are nonspecific. The most common presenting symptom in children with bronchiectasis is a persistent \"wet\" cough,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      recurrent pneumonia. Crackles and rhonchi are often heard over the area of bronchiectasis; wheezing is less common. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical manifestations'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      On chest radiograph, findings that are suspicious for bronchiectasis include linear atelectasis and dilated and thickened airways (ie, tram-tracking or parallel lines on longitudinal view, or ring shadows on cross section) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef56034 \" href=\"mobipreview.htm?14/19/14655\">",
"       image 1",
"      </a>",
"      ). High resolution computed tomography (HRCT) is the most sensitive imaging method to detect bronchiectasis. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with diffusely distributed bronchiectasis, the minimum evaluation includes testing for cystic fibrosis (sweat chloride",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      DNA testing) and immunodeficiency (including complete blood count with differential, immunoglobulins, and IgG subclasses). Ciliary dyskinesia should be considered in patients with recurrent sinus and ear infections, and evaluated with a ciliary biopsy. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Laboratory studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chronic aspiration should be considered in patients with recurrent pneumonia, particularly those with neurologic dysfunction. Potential mechanisms of aspiration should be assessed using videofluoroscopy, esophageal pH monitoring,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      nuclear scintigraphy. Direct laryngoscopy and bronchoscopy should be performed if laryngeal clefts or tracheoesophageal fistula (TEF) are suspected. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Other tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with focal bronchiectasis, imaging",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      bronchoscopy should be performed to assess for airway obstruction (eg, airway foreign body or congenital pulmonary anomalies). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Other tests'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44662/abstract/1\">",
"      Karakoc GB, Yilmaz M, Altintas DU, Kendirli SG. Bronchiectasis: still a problem. Pediatr Pulmonol 2001; 32:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44662/abstract/2\">",
"      CLARK NS. Bronchiectasis in childhood. Br Med J 1963; 1:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44662/abstract/3\">",
"      Sethi GR, Batra V. Bronchiectasis: causes and management. Indian J Pediatr 2000; 67:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44662/abstract/4\">",
"      Kumar NA, Nguyen B, Maki D. Bronchiectasis: current clinical and imaging concepts. Semin Roentgenol 2001; 36:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44662/abstract/5\">",
"      Marwah OS, Sharma OP. Bronchiectasis. How to identify, treat, and prevent. Postgrad Med 1995; 97:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44662/abstract/6\">",
"      Cockrill BA, Hales CA. Allergic bronchopulmonary aspergillosis. Annu Rev Med 1999; 50:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44662/abstract/7\">",
"      Bolman RM 3rd, Wolfe WG. Bronchiectasis and bronchopulmonary sequestration. Surg Clin North Am 1980; 60:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44662/abstract/8\">",
"      Woodring JH, Howard RS 2nd, Rehm SR. Congenital tracheobronchomegaly (Mounier-Kuhn syndrome): a report of 10 cases and review of the literature. J Thorac Imaging 1991; 6:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44662/abstract/9\">",
"      Van Schoor J, Joos G, Pauwels R. Tracheobronchomegaly--the Mounier-Kuhn syndrome: report of two cases and review of the literature. Eur Respir J 1991; 4:1303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44662/abstract/10\">",
"      Daniel TL, Woodring JH, Vandiviere HM, Wilson HD. Swyer-James syndrome--unilateral hyperlucent lung syndrome. A case report and review. Clin Pediatr (Phila) 1984; 23:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44662/abstract/11\">",
"      Koll&eacute;e LA, van Heeswijk PJ, Schretlen ED. Unilateral hyperlucent lung with decreased vascular markings (Swyer-James syndrome). Padiatr Padol 1975; 10:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44662/abstract/12\">",
"      Smith IE, Flower CD. Review article: imaging in bronchiectasis. Br J Radiol 1996; 69:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44662/abstract/13\">",
"      Rencken I, Patton WL, Brasch RC. Airway obstruction in pediatric patients. From croup to BOOP. Radiol Clin North Am 1998; 36:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44662/abstract/14\">",
"      Piccione JC, McPhail GL, Fenchel MC, et al. Bronchiectasis in chronic pulmonary aspiration: risk factors and clinical implications. Pediatr Pulmonol 2012; 47:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44662/abstract/15\">",
"      Pizzutto SJ, Grimwood K, Bauert P, et al. Bronchoscopy contributes to the clinical management of indigenous children newly diagnosed with bronchiectasis. Pediatr Pulmonol 2013; 48:67.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6360 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-61.234.146.186-3636CB1C0C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_39_44662=[""].join("\n");
var outline_f43_39_44662=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Medical history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Chest radiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - HRCT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Other tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6360\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6360|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?14/19/14655\" title=\"diagnostic image 1\">",
"      CXR bronchiect child",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?30/26/31137\" title=\"diagnostic image 2\">",
"      Bronchiectasis CT I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?19/38/20079\" title=\"diagnostic image 3\">",
"      HRCT bronchiectasis child",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?3/38/3682\" title=\"diagnostic image 4\">",
"      Central bronchiectasis CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6360|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?26/62/27630\" title=\"table 1\">",
"      Causes and evaluation of bronchiectasis in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?11/39/11900\" title=\"table 2\">",
"      Bronchiectasis by distribution",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/33/2585?source=related_link\">",
"      Airway foreign bodies in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/48/33545?source=related_link\">",
"      Allergic bronchopulmonary aspergillosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/47/30458?source=related_link\">",
"      Approach to the child with recurrent infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/46/38632?source=related_link\">",
"      Aspiration due to swallowing dysfunction in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/29/29144?source=related_link\">",
"      Bronchopulmonary sequestration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/43/16057?source=related_link\">",
"      Causes of bronchiectasis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/10/12458?source=related_link\">",
"      Clinical manifestations and diagnosis of bronchiectasis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/41/41625?source=related_link\">",
"      Clinical manifestations and diagnosis of gastroesophageal reflux disease in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/27/29114?source=related_link\">",
"      Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/42/37543?source=related_link\">",
"      Congenital anomalies of the larynx",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/49/28442?source=related_link\">",
"      Cystic fibrosis: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/45/27351?source=related_link\">",
"      Cystic fibrosis: Clinical manifestations of pulmonary disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/0/6150?source=related_link\">",
"      Management of bronchiectasis in children without cystic fibrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/27/29112?source=related_link\">",
"      Overview of pulmonary function testing in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/57/40850?source=related_link\">",
"      Patient information: Bronchiectasis in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?21/43/22195?source=related_link\">",
"      Patient information: Coughing up blood (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/37/9817?source=related_link\">",
"      Primary ciliary dyskinesia (immotile-cilia syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/48/24326?source=related_link\">",
"      Primary humoral immune deficiencies: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/4/23625?source=related_link\">",
"      Tuberculosis disease in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_39_44663="Thyroid function in nonthyroidal illness";
var content_f43_39_44663=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Thyroid function in nonthyroidal illness",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/39/44663/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/39/44663/contributors\">",
"     Douglas S Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/39/44663/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/39/44663/contributors\">",
"     David S Cooper, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/39/44663/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/39/44663/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/39/44663/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assessment of thyroid function in patients with nonthyroidal illness is difficult, especially among those hospitalized in an intensive care unit. Many of them have low serum concentrations of both thyroxine (T4) and triiodothyronine (T3) and their serum thyrotropin (TSH) concentration also may be low. Previously, these patients were thought to be euthyroid, and the term",
"    <strong>",
"     euthyroid-sick syndrome",
"    </strong>",
"    was used to describe the laboratory abnormalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/1\">",
"     1",
"    </a>",
"    ]. However, there is some evidence that these patients may have acquired transient central hypothyroidism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite these abnormalities, treatment of these patients with thyroid hormone, while controversial, appears to be of little benefit, and may be harmful [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/2\">",
"     2",
"    </a>",
"    ]. It is possible that the changes in thyroid function during severe illness are",
"    <strong>",
"     protective",
"    </strong>",
"    in that they prevent excessive tissue catabolism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will review the changes in thyroid hormone and TSH metabolism that can occur in patients with nonthyroidal illness. The utility of the different tests to assess thyroid function is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/33/3608?source=see_link\">",
"     \"Laboratory assessment of thyroid function\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are two important general principles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Thyroid function should not be assessed in seriously ill patients unless there is a strong suspicion of thyroid dysfunction.",
"     </li>",
"     <li>",
"      When thyroid dysfunction is suspected in critically ill patients, measurement of serum TSH alone is inadequate for the evaluation of thyroid function.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     LOW SERUM T3",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of hospitalized patients have low serum T3 concentrations, as do some outpatients who are ill. Unlike T4, which is produced solely within the thyroid, 80 percent of circulating T3 is produced by the peripheral 5'-deiodination of T4 to T3, a reaction catalyzed by 5'-monodeiodinases in organs such as the liver and kidney (",
"    <a class=\"graphic graphic_figure graphicRef57919 \" href=\"mobipreview.htm?7/25/7582\">",
"     figure 1",
"    </a>",
"    ). 5'-monodeiodination decreases whenever caloric intake is low and in any nonthyroidal illness, even mild illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/4\">",
"     4",
"    </a>",
"    ]. Liver and skeletal muscle biopsies obtained within minutes after death from intensive care unit patients demonstrate reduced 5'-monodeiodinase activity and increased 5-monodeiodinase activity (which converts T4 to rT3, see below) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Patients with fatal illness have low tissue T4 and T3 concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several mechanisms can contribute to the inhibition of 5'-monodeiodination and therefore to the low serum T3 concentrations in patients with nonthyroidal illness. They are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      High endogenous serum cortisol concentrations and exogenous glucocorticoid therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Circulating inhibitors of deiodinase activity, such as free (non-esterified) fatty acids [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Treatment with drugs that inhibit 5'-monodeiodinase activity such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?22/58/23466?source=see_link\">",
"       amiodarone",
"      </a>",
"      and high doses of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/49/8986?source=see_link\">",
"       propranolol",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Cytokines (such as tumor necrosis factor, interferon-alfa, NF-kB, and interleukin-6) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/11-14\">",
"       11-14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Serum samples from patients with nonthyroidal illness impair uptake of T4 into cultured rat hepatocytes, thereby reducing the availability of substrate for conversion to T3 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     When to measure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of decreased 5'-monodeiodinase activity is often not recognized, because measurement of serum T3 is rarely utilized as a screening test for thyroid function (nor should it be). It is, however, useful to measure serum T3 in hospitalized patients who have a low serum TSH concentration in whom the differential diagnosis is hyperthyroidism versus nonthyroidal illness (as an example, in a sick patient with paroxysmal atrial fibrillation). The serum T3 value should be high (or high-normal) in hyperthyroidism, but low (or low-normal) in nonthyroidal illness. Rarely, a very sick patient with hyperthyroidism will have a low serum T3 concentration. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/57/26520?source=see_link&amp;anchor=H1437846#H1437846\">",
"     \"Diagnosis of hyperthyroidism\", section on 'Critically ill patients'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Reverse T3",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reverse T3 (rT3) is the product of 5-monodeiodination of T4 (type III T4-5-deiodinase) (",
"    <a class=\"graphic graphic_figure graphicRef57919 \" href=\"mobipreview.htm?7/25/7582\">",
"     figure 1",
"    </a>",
"    ). The clearance of reverse T3 to diiodothyronine (T2) is reduced in nonthyroidal illness because of inhibition of the 5'-monodeiodinase activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/16\">",
"     16",
"    </a>",
"    ]. As a result, serum rT3 concentrations are high in patients with nonthyroidal illnesses, except in those with renal failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/17,18\">",
"     17,18",
"    </a>",
"    ] and some with AIDS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/34/33320?source=see_link\">",
"     \"Thyroid hormone synthesis and physiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     When to measure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurement of serum rT3 is occasionally useful in hospitalized patients to distinguish between nonthyroidal illness and central hypothyroidism; the values are low in the latter patients because of low production of the substrate (T4) for rT3. In patients with mild hypothyroidism, however, serum rT3 concentrations may be normal or even slightly high [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/21\">",
"     21",
"    </a>",
"    ], limiting its usefulness.",
"   </p>",
"   <p>",
"    Thyroxine sulfate (T4S) is also elevated in critical nonthyroidal illness and correlates with reduced hepatic 5'-monodeiodination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     LOW SERUM T4",
"    </span>",
"    &nbsp;&mdash;&nbsp;From 15 to 20 percent of hospitalized patients and up to 50 percent of patients in intensive care units have low serum T4 concentrations (low T4 syndrome). The concentrations are low primarily because of reductions in the serum concentrations of one or more of the three thyroid hormone-binding proteins: thyroxine-binding globulin (TBG), transthyretin (TTR, or thyroxine-binding prealbumin [TBPA]), and albumin. Since TBG is the major binding protein, low serum T4 values are likely the result of decreased production of normal TBG or production of TBG that binds T4 poorly because it is abnormally glycosylated or is cleaved in the circulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Free T4",
"    </span>",
"    &nbsp;&mdash;&nbsp;Small reductions in binding proteins should not alter serum free T4 index values, and these values are usually normal in patients whose illness is not severe. However, when the concentrations of binding proteins are very low, the T3-resin uptake test (and therefore the calculated thyroid hormone-binding ratio) fails to correct for the binding-protein deficiency adequately, and the serum free T4 index is low [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/23\">",
"     23",
"    </a>",
"    ]. The different thyroid function tests are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/33/3608?source=see_link\">",
"     \"Laboratory assessment of thyroid function\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An additional problem occurs in patients with more critical illness because some of them have circulating substances that inhibit T4 binding to the binding proteins (see below). The result is a further reduction in serum total T4 concentrations, and frequently low serum free T4 concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/24\">",
"     24",
"    </a>",
"    ] and low serum free T4 index values. However, the serum free T4 fraction measured by equilibrium dialysis may be normal or even slightly high in these patients (",
"    <a class=\"graphic graphic_figure graphicRef61095 \" href=\"mobipreview.htm?41/37/42589\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/25\">",
"     25",
"    </a>",
"    ]. In one study, as an example, none of 25 patients with nonthyroid illness had a low serum concentration of free T4 by equilibrium dialysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/26\">",
"     26",
"    </a>",
"    ]. The effects of non-thyroidal illness and drugs on \"direct\" free T4 measurements may be method dependent and result in spuriously high or low values, leading one expert in this field to conclude: \"Despite the theoretical attraction of measuring the concentration of free or biologically active hormone, it remains uncertain whether current free T4 methodology is any improvement over an uncontentious measurement of total T4\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Possible contributing factors for decreased T4 and free T4: inhibitors of T4 binding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Controversy exists as to the cause and importance of inhibitors of T4 binding to its binding proteins in patients with nonthyroidal illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/25\">",
"     25",
"    </a>",
"    ]. Some data support the possibility that high serum free fatty acid concentrations inhibit T4 binding to serum proteins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Serum free fatty acid, particularly oleic acid, concentrations may be high in critically ill patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/30\">",
"     30",
"    </a>",
"    ], and their effect on T4 binding may be increased because of hypoalbuminemia, because albumin is the major carrier of free fatty acids in serum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/31\">",
"     31",
"    </a>",
"    ]. However, this phenomenon may be an in vitro effect of fatty acids released during collection and transport of the serum sample [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/32\">",
"     32",
"    </a>",
"    ]. Inhibitors may also interfere with the T3-resin uptake test by interacting with the solid matrices used in the test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Transient central hypothyroidism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with severe nonthyroidal illness may have acquired transient central hypothyroidism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/1\">",
"     1",
"    </a>",
"    ]. This suggestion is supported by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A prospective study evaluated changes in thyroid function in patients undergoing bone marrow transplantation: serum TSH concentrations fell coincident with declines in serum T4 concentrations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A study of critically ill patients recovering from nonthyroidal illness demonstrated that a rise in serum TSH concentration (which transiently reached supranormal values in some patients)",
"      <strong>",
"       preceded",
"      </strong>",
"      normalization of serum T4 concentrations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients with nonthyroidal illness, similar to those with central hypothyroidism from other causes, have a blunted nocturnal rise in serum TSH concentrations, but usually have a normal serum TSH response to thyrotropin-releasing hormone (TRH) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Abnormalities in TSH glycosylation that may decrease TSH bioactivity have been found in patients with nonthyroidal illness [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/37\">",
"       37",
"      </a>",
"      ], and also in patients with central hypothyroidism [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      TRH mRNA in the paraventricular nucleus of the hypothalamus was reduced in patients who died with nonthyroidal illness in one report, and was correlated with premortem serum T3 and TSH concentrations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      TRH infusion in patients with critical illness raises serum TSH, T4, and T3 concentrations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Infusion of interferon-alfa to eight normal men caused a fall in serum TSH and T3 concentrations as well as a rise in the serum concentrations of rT3 and interleukin-6, thus mimicking the thyroid metabolic changes of serious illness, except that there was no fall in the serum T4 concentration [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SERUM TSH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum TSH assays that have a detection limit of 0.01",
"    <span class=\"nowrap\">",
"     mU/L",
"    </span>",
"    should be used in assessing thyroid function in critically ill patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/41\">",
"     41",
"    </a>",
"    ]. TSH results should be interpreted as follows:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Low but detectable",
"    </span>",
"    &nbsp;&mdash;&nbsp;Almost all patients who have a subnormal but detectable serum TSH concentration (greater than 0.05",
"    <span class=\"nowrap\">",
"     mU/L",
"    </span>",
"    and less than 0.3",
"    <span class=\"nowrap\">",
"     mU/L)",
"    </span>",
"    will be euthyroid when reassessed after recovery from their illness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Undetectable",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast, approximately 75 percent of patients with undetectable serum TSH concentrations (&lt;0.01",
"    <span class=\"nowrap\">",
"     mU/L)",
"    </span>",
"    have hyperthyroidism. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/33/3608?source=see_link\">",
"     \"Laboratory assessment of thyroid function\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     High",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, some hospitalized patients have transient elevations in serum TSH concentrations (up to 20",
"    <span class=\"nowrap\">",
"     mU/L)",
"    </span>",
"    during recovery from nonthyroidal illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/41\">",
"     41",
"    </a>",
"    ]. Few of these patients prove to have hypothyroidism when reevaluated after recovery from their illness. Patients with serum TSH concentrations over 20",
"    <span class=\"nowrap\">",
"     mU/L",
"    </span>",
"    usually have permanent hypothyroidism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     EFFECTS OF DRUGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hospitalized patients frequently receive medications that have important effects on thyroid function or on thyroid function tests (",
"    <a class=\"graphic graphic_table graphicRef50439 \" href=\"mobipreview.htm?21/19/21820\">",
"     table 1",
"    </a>",
"    ). Dopamine,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    , glucocorticoids,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/52/28488?source=see_link\">",
"     furosemide",
"    </a>",
"    , nonsteroidal anti-inflammatory drugs,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    , anticonvulsants,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    , and drugs that affect TBG can alter thyroid function tests. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/40/42632?source=see_link\">",
"     \"Drug interactions with thyroid hormones\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/53/856?source=see_link\">",
"     \"Euthyroid hyperthyroxinemia and hypothyroxinemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SPECIFIC NONTHYROIDAL ILLNESSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several disease states are associated with abnormal thyroid function tests including acute hepatitis, hepatoma, acute intermittent porphyria, acromegaly, nephrotic syndrome, Cushing's syndrome, acute psychosis, and depression. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/53/856?source=see_link\">",
"     \"Euthyroid hyperthyroxinemia and hypothyroxinemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/51/43829?source=see_link\">",
"     \"Endocrine dysfunction in the nephrotic syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Psychiatric illness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients with acute psychiatric illnesses, particularly schizophrenia, have transient elevations in serum T4 concentrations with or without low serum TSH concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/43-45\">",
"     43-45",
"    </a>",
"    ]. Patients with severe depression may have changes similar to those of patients with glucocorticoid excess. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/53/856?source=see_link\">",
"     \"Euthyroid hyperthyroxinemia and hypothyroxinemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The magnitude of the changes in thyroid function in patients with nonthyroidal illness varies with the severity of the illness (",
"    <a class=\"graphic graphic_figure graphicRef61095 \" href=\"mobipreview.htm?41/37/42589\">",
"     figure 2",
"    </a>",
"    ). Thus, the",
"    <strong>",
"     serum free T4 index",
"    </strong>",
"    value correlates with outcome; values under 3 have been associated with mortality rates in excess of 85 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/46\">",
"     46",
"    </a>",
"    ]. Similarly high rT3 and a low",
"    <span class=\"nowrap\">",
"     T3/rT3",
"    </span>",
"    ratio on the first day in an intensive care unit correlated with increased mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/33/3608?source=see_link&amp;anchor=H5#H5\">",
"     \"Laboratory assessment of thyroid function\", section on 'Serum free T4 and free T3'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Thyroid hormone replacement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyroid hormone replacement has not been shown to be effective for patients with critical illness and low T3",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    T4, or for patients undergoing cardiopulmonary bypass. The data on thyroid hormone replacement in experimental and clinical conditions is summarized here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Thyroid hormone during fasting",
"    </span>",
"    &nbsp;&mdash;&nbsp;During fasting, there is an associated decrease in serum T3 concentrations that spares muscle protein. T3 replacement results in increased catabolism with breakdown of skeletal muscle [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/47,48\">",
"     47,48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Critical illness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyroid hormone replacement does not appear to be beneficial for critically ill patients with low serum T3",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    low T4 concentrations. In a randomized trial of burn patients with low free T4 index and free T3 index levels, T3 replacement had no effect on mortality or metabolic rate when compared with placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/49\">",
"     49",
"    </a>",
"    ]. In a second trial, administration of T4 to 23 critically ill patients with low serum T4 concentrations did not alter either mortality or outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     CABG",
"    </span>",
"    &nbsp;&mdash;&nbsp;During and after cardiopulmonary bypass, there is a transient decrease in serum T3 concentrations, which may contribute to postoperative hemodynamic problems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/48\">",
"     48",
"    </a>",
"    ]. While animal data and anecdotal clinical experience had suggested that T3 repletion might improve outcomes after cardiopulmonary bypass [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/51,52\">",
"     51,52",
"    </a>",
"    ], clinical trials have not demonstrated such a benefit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/53-55\">",
"     53-55",
"    </a>",
"    ]. In a systematic review of 14 randomized trials evaluating the administration of T3 in euthyroid adult patients in the immediate postoperative period (13 cardiac surgery, one renal transplantation), intravenous (IV) T3 administration increased cardiac index [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/56\">",
"     56",
"    </a>",
"    ]. Mortality was not affected by high-dose IV T3 and could not be assessed for low dose IV or oral T3. In one of the trials included in the meta-analysis, 142 patients with coronary heart disease undergoing coronary artery bypass surgery (CABG) were randomly assigned to intravenous T3 therapy (0.8",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    bolus followed by an infusion of 0.113",
"    <span class=\"nowrap\">",
"     mcg/kg/hour",
"    </span>",
"    for six hours) at the completion of surgery or placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44663/abstract/53\">",
"     53",
"    </a>",
"    ]. Although the mean cardiac index was higher and systemic vascular resistance was lower in the T3 group compared with placebo, there were no differences in the incidence of arrhythmia, need for inotropic or vasodilator drugs during the 24 hours after surgery, or in perioperative morbidity and mortality.",
"    <br/>",
"   </p>",
"   <p>",
"    In summary, there is no evidence that thyroid hormone replacement is beneficial for patients with critical illness who have low serum T4 or T3 concentrations, or for patients undergoing CABG, whose serum T3 concentrations are known to decrease in the perioperative period. If, however, there is evidence to support a diagnosis of hypothyroidism (such as a TSH over 20",
"    <span class=\"nowrap\">",
"     mU/L",
"    </span>",
"    with low free T4",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    history, symptoms, and signs of hypothyroidism), cautious administration of thyroid hormone is appropriate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    Assessment of thyroid function in patients with nonthyroidal illness is difficult, especially among those hospitalized in an intensive care unit. Many of them have low serum concentrations of thyroxine (T4), free T4, and triiodothyronine (T3) and their serum thyrotropin (TSH) concentrations may also be low.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     When to test",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend that thyroid function tests not be measured on seriously ill patients unless there is a strong suspicion of thyroid dysfunction.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     What to test",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      When thyroid dysfunction is suspected in critically ill patients, measurement of serum TSH alone is inadequate for the evaluation of thyroid function. In this case, we suggest measurement of a full thyroid panel including a total T4, a free T4, and a T3. However, the diagnosis may still be in doubt. All methods for assessing free T4 levels are unreliable in severe critical illness; a free T4 by equilibrium dialysis sent to a reference lab would be the least likely to provide spurious results. Some experts argue a total T4 is of similar utility, at considerably less cost.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In critically ill patients with low serum T3",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      low T4 concentrations and no other clinical signs of hypothyroidism, we suggest",
"      <strong>",
"       not",
"      </strong>",
"      treating with thyroid hormone (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Critical illness'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In previously euthyroid patients undergoing CABG, we recommend",
"      <strong>",
"       not",
"      </strong>",
"      treating with thyroid hormone in the immediate post-operative period (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H22\">",
"       'CABG'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If there is additional evidence to suggest a diagnosis of hypothyroidism in critically ill patients, we suggest that patients receive thyroid hormone replacement (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). In the absence of suspected myxedema coma, repletion should be cautious, beginning with approximately half the expected full replacement dose of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?40/43/41656?source=see_link\">",
"       levothyroxine",
"      </a>",
"      . (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/23/8566?source=see_link\">",
"       \"Myxedema coma\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/53/43865?source=see_link\">",
"       \"Treatment of hypothyroidism\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/1\">",
"      Chopra IJ. Clinical review 86: Euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metab 1997; 82:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/2\">",
"      Utiger RD. Altered thyroid function in nonthyroidal illness and surgery. To treat or not to treat? N Engl J Med 1995; 333:1562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/3\">",
"      Stockigt JR. Guidelines for diagnosis and monitoring of thyroid disease: nonthyroidal illness. Clin Chem 1996; 42:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/4\">",
"      Davidson MB, Chopra IJ. Effect of carbohydrate and noncarbohydrate sources of calories on plasma 3,5,3'-triiodothyronine concentrations in man. J Clin Endocrinol Metab 1979; 48:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/5\">",
"      Peeters RP, Wouters PJ, Kaptein E, et al. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab 2003; 88:3202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/6\">",
"      Peeters RP, Wouters PJ, van Toor H, et al. Serum 3,3',5'-triiodothyronine (rT3) and 3,5,3'-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. J Clin Endocrinol Metab 2005; 90:4559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/7\">",
"      Peeters RP, Kester MH, Wouters PJ, et al. Increased thyroxine sulfate levels in critically ill patients as a result of a decreased hepatic type I deiodinase activity. J Clin Endocrinol Metab 2005; 90:6460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/8\">",
"      Arem R, Wiener GJ, Kaplan SG, et al. Reduced tissue thyroid hormone levels in fatal illness. Metabolism 1993; 42:1102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/9\">",
"      Chopra IJ, Williams DE, Orgiazzi J, Solomon DH. Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3). J Clin Endocrinol Metab 1975; 41:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/10\">",
"      Chopra IJ, Huang TS, Beredo A, et al. Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3,5,3'-triiodothyronine in sera of patients with nonthyroidal illnesses. J Clin Endocrinol Metab 1985; 60:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/11\">",
"      van der Poll T, Romijn JA, Wiersinga WM, Sauerwein HP. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 1990; 71:1567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/12\">",
"      Stouthard JM, van der Poll T, Endert E, et al. Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J Clin Endocrinol Metab 1994; 79:1342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/13\">",
"      Corssmit EP, Heyligenberg R, Endert E, et al. Acute effects of interferon-alpha administration on thyroid hormone metabolism in healthy men. J Clin Endocrinol Metab 1995; 80:3140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/14\">",
"      Nagaya T, Fujieda M, Otsuka G, et al. A potential role of activated NF-kappa B in the pathogenesis of euthyroid sick syndrome. J Clin Invest 2000; 106:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/15\">",
"      Vos RA, De Jong M, Bernard BF, et al. Impaired thyroxine and 3,5,3'-triiodothyronine handling by rat hepatocytes in the presence of serum of patients with nonthyroidal illness. J Clin Endocrinol Metab 1995; 80:2364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/16\">",
"      Chopra IJ. An assessment of daily production and significance of thyroidal secretion of 3, 3', 5'-triiodothyronine (reverse T3) in man. J Clin Invest 1976; 58:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/17\">",
"      Kaptein EM, Feinstein EI, Nicoloff JT, Massry SG. Serum reverse triiodothyronine and thyroxine kinetics in patients with chronic renal failure. J Clin Endocrinol Metab 1983; 57:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/18\">",
"      Kaptein EM. Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr Rev 1996; 17:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/19\">",
"      LoPresti JS, Fried JC, Spencer CA, Nicoloff JT. Unique alterations of thyroid hormone indices in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989; 110:970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/20\">",
"      Ricart-Engel W, Fern&aacute;ndez-Real JM, Gonz&aacute;lez-Huix F, et al. The relation between thyroid function and nutritional status in HIV-infected patients. Clin Endocrinol (Oxf) 1996; 44:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/21\">",
"      Burmeister LA. Reverse T3 does not reliably differentiate hypothyroid sick syndrome from euthyroid sick syndrome. Thyroid 1995; 5:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/22\">",
"      Jirasakuldech B, Schussler GC, Yap MG, et al. A characteristic serpin cleavage product of thyroxine-binding globulin appears in sepsis sera. J Clin Endocrinol Metab 2000; 85:3996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/23\">",
"      Chopra IJ, Solomon DH, Hepner GW, Morgenstein AA. Misleadingly low free thyroxine index and usefulness of reverse triiodothyronine measurement in nonthyroidal illnesses. Ann Intern Med 1979; 90:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/24\">",
"      Wong TK, Pekary AE, Hoo GS, et al. Comparison of methods for measuring free thyroxin in nonthyroidal illness. Clin Chem 1992; 38:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/25\">",
"      Docter R, Krenning EP, de Jong M, Hennemann G. The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol (Oxf) 1993; 39:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/26\">",
"      Chopra IJ. Simultaneous measurement of free thyroxine and free 3,5,3'-triiodothyronine in undiluted serum by direct equilibrium dialysis/radioimmunoassay: evidence that free triiodothyronine and free thyroxine are normal in many patients with the low triiodothyronine syndrome. Thyroid 1998; 8:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/27\">",
"      Stockigt J. Assessment of thyroid function: towards an integrated laboratory--clinical approach. Clin Biochem Rev 2003; 24:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/28\">",
"      Chopra IJ, Teco GN, Mead JF, et al. Relationship between serum free fatty acids and thyroid hormone binding inhibitor in nonthyroid illnesses. J Clin Endocrinol Metab 1985; 60:980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/29\">",
"      Lim CF, Bernard BF, de Jong M, et al. A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia. J Clin Endocrinol Metab 1993; 76:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/30\">",
"      Lim CF, Curtis AJ, Barlow JW, et al. Interactions between oleic acid and drug competitors influence specific binding of thyroxine in serum. J Clin Endocrinol Metab 1991; 73:1106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/31\">",
"      Mendel CM, Frost PH, Cavalieri RR. Effect of free fatty acids on the concentration of free thyroxine in human serum: the role of albumin. J Clin Endocrinol Metab 1986; 63:1394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/32\">",
"      Mendel CM, Laughton CW, McMahon FA, Cavalieri RR. Inability to detect an inhibitor of thyroxine-serum protein binding in sera from patients with nonthyroid illness. Metabolism 1991; 40:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/33\">",
"      Oppenheimer JH, Schwartz HL, Mariash CN, Kaiser FE. Evidence for a factor in the sera of patients with nonthyroidal disease which inhibits iodothyronine binding by solid matrices, serum proteins, and rat hepatocytes. J Clin Endocrinol Metab 1982; 54:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/34\">",
"      Wehmann RE, Gregerman RI, Burns WH, et al. Suppression of thyrotropin in the low-thyroxine state of severe nonthyroidal illness. N Engl J Med 1985; 312:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/35\">",
"      Hamblin PS, Dyer SA, Mohr VS, et al. Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness. J Clin Endocrinol Metab 1986; 62:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/36\">",
"      Romijn JA, Wiersinga WM. Decreased nocturnal surge of thyrotropin in nonthyroidal illness. J Clin Endocrinol Metab 1990; 70:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/37\">",
"      Lee HY, Suhl J, Pekary AE, Hershman JM. Secretion of thyrotropin with reduced concanavalin-A-binding activity in patients with severe nonthyroid illness. J Clin Endocrinol Metab 1987; 65:942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/38\">",
"      Persani L, Ferretti E, Borgato S, et al. Circulating thyrotropin bioactivity in sporadic central hypothyroidism. J Clin Endocrinol Metab 2000; 85:3631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/39\">",
"      Fliers E, Guldenaar SE, Wiersinga WM, Swaab DF. Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. J Clin Endocrinol Metab 1997; 82:4032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/40\">",
"      Van den Berghe G, Wouters P, Weekers F, et al. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab 1999; 84:1311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/41\">",
"      Spencer CA, LoPresti JS, Patel A, et al. Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. J Clin Endocrinol Metab 1990; 70:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/42\">",
"      Attia J, Margetts P, Guyatt G. Diagnosis of thyroid disease in hospitalized patients: a systematic review. Arch Intern Med 1999; 159:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/43\">",
"      Spratt DI, Pont A, Miller MB, et al. Hyperthyroxinemia in patients with acute psychiatric disorders. Am J Med 1982; 73:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/44\">",
"      Chopra IJ, Solomon DH, Huang TS. Serum thyrotropin in hospitalized psychiatric patients: evidence for hyperthyrotropinemia as measured by an ultrasensitive thyrotropin assay. Metabolism 1990; 39:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/45\">",
"      Roca RP, Blackman MR, Ackerley MB, et al. Thyroid hormone elevations during acute psychiatric illness: relationship to severity and distinction from hyperthyroidism. Endocr Res 1990; 16:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/46\">",
"      Slag MF, Morley JE, Elson MK, et al. Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA 1981; 245:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/47\">",
"      Vignati L, Finley RJ, Hagg S, Aoki TT. Protein conservation during prolonged fast: a function of triiodothyronine levels. Trans Assoc Am Physicians 1978; 91:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/48\">",
"      Gardner DF, Kaplan MM, Stanley CA, Utiger RD. Effect of tri-iodothyronine replacement on the metabolic and pituitary responses to starvation. N Engl J Med 1979; 300:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/49\">",
"      Becker RA, Vaughan GM, Ziegler MG, et al. Hypermetabolic low triiodothyronine syndrome of burn injury. Crit Care Med 1982; 10:870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/50\">",
"      Brent GA, Hershman JM. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab 1986; 63:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/51\">",
"      Broderick TJ, Wechsler AS. Triiodothyronine in cardiac surgery. Thyroid 1997; 7:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/52\">",
"      Novitzky D, Fontanet H, Snyder M, et al. Impact of triiodothyronine on the survival of high-risk patients undergoing open heart surgery. Cardiology 1996; 87:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/53\">",
"      Klemperer JD, Klein I, Gomez M, et al. Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 1995; 333:1522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/54\">",
"      Bennett-Guerrero E, Jimenez JL, White WD, et al. Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. A randomized, double-blind, placebo- controlled trial. Duke T3 study group. JAMA 1996; 275:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/55\">",
"      Spratt DI, Frohnauer M, Cyr-Alves H, et al. Physiological effects of nonthyroidal illness syndrome in patients after cardiac surgery. Am J Physiol Endocrinol Metab 2007; 293:E310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44663/abstract/56\">",
"      Kaptein EM, Sanchez A, Beale E, Chan LS. Clinical review: Thyroid hormone therapy for postoperative nonthyroidal illnesses: a systematic review and synthesis. J Clin Endocrinol Metab 2010; 95:4526.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7817 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-118.195.65.247-9CA6F9C4F1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_39_44663=[""].join("\n");
var outline_f43_39_44663=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      LOW SERUM T3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      When to measure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Reverse T3",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - When to measure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      LOW SERUM T4",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Free T4",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Possible contributing factors for decreased T4 and free T4: inhibitors of T4 binding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Transient central hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SERUM TSH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Low but detectable",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Undetectable",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      High",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      EFFECTS OF DRUGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SPECIFIC NONTHYROIDAL ILLNESSES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Psychiatric illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Thyroid hormone replacement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Thyroid hormone during fasting",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Critical illness",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - CABG",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      When to test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      What to test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7817\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7817|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?7/25/7582\" title=\"figure 1\">",
"      Thyroxine metabolism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?41/37/42589\" title=\"figure 2\">",
"      Thyroid function sick patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7817|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?21/19/21820\" title=\"table 1\">",
"      Drugs and thyroid function",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/57/26520?source=related_link\">",
"      Diagnosis of hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/40/42632?source=related_link\">",
"      Drug interactions with thyroid hormones",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/51/43829?source=related_link\">",
"      Endocrine dysfunction in the nephrotic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/53/856?source=related_link\">",
"      Euthyroid hyperthyroxinemia and hypothyroxinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/33/3608?source=related_link\">",
"      Laboratory assessment of thyroid function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/23/8566?source=related_link\">",
"      Myxedema coma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/34/33320?source=related_link\">",
"      Thyroid hormone synthesis and physiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/53/43865?source=related_link\">",
"      Treatment of hypothyroidism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_39_44664="Hypoglycemia in adults: Clinical manifestations, definition, and causes";
var content_f43_39_44664=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hypoglycemia in adults: Clinical manifestations, definition, and causes",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/39/44664/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/39/44664/contributors\">",
"     F John Service, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/39/44664/contributors\">",
"     Philip E Cryer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/39/44664/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/39/44664/contributors\">",
"     Irl B Hirsch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/39/44664/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/39/44664/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/39/44664/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 5, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients without diabetes, hypoglycemia is a clinical syndrome with diverse causes in which low plasma glucose concentrations lead to symptoms and signs, and there is resolution of the",
"    <span class=\"nowrap\">",
"     symptoms/signs",
"    </span>",
"    when the plasma glucose concentration is raised [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/1\">",
"     1",
"    </a>",
"    ]. In patients with diabetes, hypoglycemia is defined as all episodes of an abnormally low plasma glucose concentration (with or without symptoms) that expose the individual to harm. In patients with diabetes, the hypoglycemia symptoms and signs occur as a consequence of therapy. The primary task in a patient without diabetes is to make an accurate diagnosis, whereas the primary task in a patient with diabetes is to alter therapy in an attempt to minimize or eliminate hypoglycemia.",
"   </p>",
"   <p>",
"    This topic will review the clinical manifestations, definitions, and causes of clinical hypoglycemia. The evaluation of patients with hypoglycemia, detailed information on specific causes, and the management of hypoglycemia in patients with diabetes are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/39/24184?source=see_link\">",
"     \"Hypoglycemia in adults without diabetes mellitus: Diagnostic approach\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/30/12777?source=see_link\">",
"     \"Insulinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/32/18951?source=see_link\">",
"     \"Factitious hypoglycemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/12/11461?source=see_link\">",
"     \"Nonislet cell tumor hypoglycemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/63/27641?source=see_link\">",
"     \"Management of hypoglycemia during treatment of diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients who have only sympathoadrenal symptoms (anxiety, weakness, tremor, perspiration, or palpitations) but normal concurrent plasma glucose concentrations have a low probability of having a hypoglycemic disorder. This combination is most common in patients with postprandial symptoms. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/11/3255?source=see_link&amp;anchor=H4#H4\">",
"     \"Postprandial (reactive) hypoglycemia\", section on 'Postprandial syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28642693\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypoglycemia is common in type 1 diabetes, especially in patients receiving intensive therapy, in whom the risk of severe hypoglycemia is increased more than threefold. Plasma glucose concentrations may be less than 50 to 60",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2.8 to 3.3",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    as much as 10 percent of the time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/2\">",
"     2",
"    </a>",
"    ]. They suffer an average of two episodes of symptomatic hypoglycemia per week, thousands of such episodes over a lifetime of diabetes, and one episode of severe, at least temporarily disabling hypoglycemia per year. Severe hypoglycemia events, the most reliable values albeit representing only a small fraction of the total hypoglycemic experience, have been reported to range from 62 to 320 episodes per 100 patient years in type 1 diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hypoglycemia is less frequent in type 2 diabetes than it is in type 1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/2,4\">",
"     2,4",
"    </a>",
"    ]. Population-based data indicate that the overall event rate for severe hypoglycemia (requiring the assistance of another individual) in insulin-treated type 2 diabetes is approximately 30 percent of that in type 1 diabetes (35 versus 115 episodes per 100 patient-years) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/5\">",
"     5",
"    </a>",
"    ] and that event rates for hypoglycemia requiring professional emergency medical treatment range from 40 to 100 percent of those in type 1 diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Over time, the frequency of hypoglycemia in patients with type 2 diabetes approaches that in type 1 diabetes as patients with type 2 diabetes approach the insulin deficient end of the spectrum of the disease and require aggressive treatment with insulin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/1,2,4\">",
"     1,2,4",
"    </a>",
"    ]. This difference in the incidence of iatrogenic hypoglycemia (relatively high throughout the course of type 1 diabetes but progressing from relatively low to relatively high over the course of type 2 diabetes) is a function of the pathophysiology of glucose counterregulation, specifically the rate of beta cell failure and the resulting rate of alpha cell failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/2,4\">",
"     2,4",
"    </a>",
"    ]. The pathophysiology of glucose counterregulation is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/60/29638?source=see_link\">",
"     \"Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast to patients with diabetes, hypoglycemia is uncommon in individuals who do not have drug-treated diabetes mellitus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. In a retrospective review of 37,898 non-diabetic, non-critical care hospital admissions, the estimated frequency of hypoglycemia (&le;55",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [3.0",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    was 36 per 10,000 admissions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/10\">",
"     10",
"    </a>",
"    ]. In these patients, hypoglycemia was caused by a variety of non-diabetes drugs, including alcohol, and common critical illnesses such as hepatic, renal, or cardiac failure, sepsis, or inanition. Most patients had multiple possible reasons for hypoglycemia. Only seven patients had unexplained hypoglycemia, which did not recur during the inpatient admission. There are few data on the frequency of unexplained hypoglycemia in the outpatient setting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The symptoms of hypoglycemia in patients with and without diabetes are nonspecific. Hypoglycemia causes neurogenic (autonomic) and neuroglycopenic symptoms. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/60/29638?source=see_link\">",
"     \"Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The neurogenic symptoms include tremor, palpitations, and",
"      <span class=\"nowrap\">",
"       anxiety/arousal",
"      </span>",
"      (catecholamine-mediated, adrenergic) and sweating, hunger, and paresthesias (acetylcholine-mediated, cholinergic) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/2,11,12\">",
"       2,11,12",
"      </a>",
"      ]. They are largely caused by sympathetic neural, rather than adrenomedullary, activation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The neuroglycopenic symptoms include cognitive impairment, behavioral changes, psychomotor abnormalities and, at lower plasma glucose concentrations, seizure and coma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/11,12,14\">",
"       11,12,14",
"      </a>",
"      ]. Although profound prolonged hypoglycemia can cause brain death in the unobserved patient with diabetes, the vast majority of episodes are reversed after the glucose level is raised to normal and the rare fatal episodes are generally thought to be the result of ventricular arrhythmia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the patient without diabetes, the presence of neuroglycopenic symptoms provides more clinically compelling evidence of an underlying hypoglycemic disorder, as the neurogenic symptoms are particularly nonspecific [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/1\">",
"     1",
"    </a>",
"    ]. Recognition of neurogenic symptoms by patients with diabetes, however, can lead to prompt self-treatment.",
"   </p>",
"   <p>",
"    The symptoms the patient does have tend to occur consistently from episode to episode and may occur in the fasting or postprandial state. The symptoms may not be recognized by the patient, even though they are evident to an observer. Furthermore, many patients cannot describe their episodes in any detail because of amnesia, so that information should be obtained from a close family member or friend whenever possible.",
"   </p>",
"   <p>",
"    The symptoms may also be absent because of hypoglycemia unawareness, which is thought to be the result of reduced sympathoadrenal, predominantly sympathetic neural, responses to a given degree of hypoglycemia caused by recent antecedent hypoglycemia, prior exercise, or sleep in patients with diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/60/29638?source=see_link&amp;anchor=H12#H12\">",
"     \"Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus\", section on 'Hypoglycemia-associated autonomic failure'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients who have only sympathoadrenal symptoms (anxiety, weakness, tremor, perspiration, or palpitations), but normal concurrent plasma glucose concentrations, and resolution of symptoms after dietary modification have a low probability of having a hypoglycemic disorder. This combination is most common in patients with postprandial symptoms. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/11/3255?source=see_link&amp;anchor=H4#H4\">",
"     \"Postprandial (reactive) hypoglycemia\", section on 'Postprandial syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diaphoresis and pallor are common signs of hypoglycemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Heart rates and systolic blood pressures are raised, but not greatly. Neuroglycopenic manifestations are often observable. Occasionally, transient neurological deficits occur. Permanent neurological damage is rare and, should it occur, it would be more likely in a patient with diabetes and prolonged severe hypoglycemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lower limit of the normal fasting plasma glucose value is typically 70",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (3.9",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    In nondiabetic persons, the secretion of insulin decreases as glucose levels decline within the physiological range, and the release of counterregulatory hormones, glucagon and epinephrine, increases when the glucose concentration falls to 65 to 70",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (3.6 to 3.9",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    Growth hormone and cortisol secretion also increase at similar plasma glucose concentrations. These hormonal responses begin well before the onset of symptoms of hypoglycemia, which normally occur at glucose levels of 50 to 55",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2.8 to 3.0",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    It is important to note, however, that the hypoglycemic thresholds are variable. The glycemic thresholds for these responses shift to higher plasma glucose concentrations in patients with poorly controlled diabetes and to lower plasma glucose concentrations in patients with repeated episodes of hypoglycemia, such as may be caused by intensive therapy of diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/15\">",
"     15",
"    </a>",
"    ] or an insulinoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/60/29638?source=see_link&amp;anchor=H4#H4\">",
"     \"Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus\", section on 'Counterregulatory hormones'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11376092\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Patients with diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with diabetes, hypoglycemia is defined as all episodes of an abnormally low plasma glucose concentration (with or without symptoms) that expose the individual to harm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/17\">",
"     17",
"    </a>",
"    ]. People with diabetes should become concerned about the possibility of hypoglycemia at a self-monitored blood glucose (SMBG) level &le;70",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (3.9",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    While this value is higher than the value used to diagnose hypoglycemia in people without diabetes, it reflects the high probability that persons treated with insulin may have repeated episodes of hypoglycemia related to treatment and the importance of detecting episodes early before they become clinically severe. This value also approximates the lower limit of the physiological fasting nondiabetic range, the normal glycemic threshold for glucose counterregulatory hormone secretion, and the highest antecedent low glucose level reported to reduce sympathoadrenal responses to subsequent hypoglycemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This cut-off value has been debated, with some favoring a value of &lt;63",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (3.5",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    to avoid overclassification of hypoglycemia in asymptomatic diabetic patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/18-21\">",
"     18-21",
"    </a>",
"    ]. However, when an SMBG value is &le;70",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    it does not mean that patients should always self-treat. Defensive options include repeating the measurement in the near term, avoiding critical tasks such as driving, adjusting the subsequent treatment regimen, or ingesting carbohydrates. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/63/27641?source=see_link\">",
"     \"Management of hypoglycemia during treatment of diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Patients without diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a person without diabetes, the presence of a hypoglycemic disorder cannot be diagnosed with confidence solely on the basis of a low plasma glucose concentration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/1\">",
"     1",
"    </a>",
"    ]. Although neurogenic and neuroglycopenic symptoms may be highly suggestive of hypoglycemia, they cannot be ascribed to hypoglycemia with confidence unless the plasma glucose concentration is low at the same time, and the symptoms are relieved when it is raised [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/1\">",
"     1",
"    </a>",
"    ]. This triad of symptoms, a low plasma glucose concentration, and relief by raising plasma glucose, was coined by Whipple in 1938 and bears his name, Whipple's triad [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/22\">",
"     22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Recognize that the patient's symptoms could be caused by hypoglycemia",
"     </li>",
"     <li>",
"      Document that the patient's plasma glucose concentrations are low when the symptoms are present",
"     </li>",
"     <li>",
"      Show that the symptoms can be relieved by administration of glucose",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A hypoglycemic disorder should be diagnosed only in those in whom Whipple's triad is documented, and only those patients in whom Whipple's triad is documented require evaluation and management of hypoglycemia. However, reliably measured severely depressed plasma glucose concentrations (&lt;40",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [2.2",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    in the absence of symptoms should not be ignored. This may occur in patients with repeated episodes of hypoglycemia or artifactual hypoglycemia. (See",
"    <a class=\"local\" href=\"#H18546202\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Although low blood glucose values measured using reflectance meters suggest the presence of hypoglycemia, these methods are not reliable to diagnose hypoglycemia in the absence of insulin or insulin secretagogue treatment of diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/1,23\">",
"     1,23",
"    </a>",
"    ]. Thus, a patient who has a single low blood glucose value measured by a meter but no symptoms of hypoglycemia probably does not need further evaluation; on the other hand, evaluation is indicated in a patient who has repeated low values. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/39/24184?source=see_link\">",
"     \"Hypoglycemia in adults without diabetes mellitus: Diagnostic approach\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18546202\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A low plasma glucose concentration in the absence of symptoms of hypoglycemia suggests the possibility of shifted glycemic thresholds, as may occur in patients with repeated episodes of hypoglycemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/2,15,17\">",
"     2,15,17",
"    </a>",
"    ], or artifactual hypoglycemia. The latter can occur if an antiglycolytic agent (such as fluoride) is not present in the blood-collection tube and processing is delayed, particularly in samples from patients with leukemia, in which the large numbers of leukocytes consume glucose, and in samples from patients with severe hemolytic disease or erythrocytosis, in which the nucleated red blood cells or erythrocytes consume glucose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/24-27\">",
"     24-27",
"    </a>",
"    ]. This problem tends to be greater if glucose is measured in serum and the blood sample is not processed quickly. Thus, reliably measured low plasma glucose concentrations should not be ignored. The measurement should be repeated using a collection tube that contains an inhibitor of glycolysis, and processing should not be delayed.",
"   </p>",
"   <p>",
"    For patients with diabetes who may have asymptomatic hypoglycemia due to repeated episodes of hypoglycemia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hypoglycemia unawareness, intermittent use of continuous glucose monitoring may be valuable for the detection of nocturnal hypoglycemia or patterns of hypoglycemia. For the rare patient without diabetes having repeated episodes of asymptomatic hypoglycemia (&lt;40",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [2.2",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    and in whom artifactual hypoglycemia has been ruled out, further evaluation to assess the genesis of the hypoglycemia is necessary. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/60/29641?source=see_link&amp;anchor=H13#H13\">",
"     \"Blood glucose self-monitoring in management of adults with diabetes mellitus\", section on 'Continuous glucose monitoring'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/39/24184?source=see_link&amp;anchor=H3#H3\">",
"     \"Hypoglycemia in adults without diabetes mellitus: Diagnostic approach\", section on 'Approach to testing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients without diabetes who have only autonomic symptoms (tremor, palpitations, anxiety, sweating, hunger) but unequivocally normal (&gt;70",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [3.9",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    plasma glucose concentrations during symptoms do not have a hypoglycemic disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/8\">",
"     8",
"    </a>",
"    ]. The differential diagnosis of autonomic symptoms is extensive and includes postprandial syndrome, cardiac disease (arrhythmia, valvular heart disease), medications, psychiatric disease, and metabolic disorders (hyperthyroidism, pheochromocytoma). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/11/3255?source=see_link&amp;anchor=H4#H4\">",
"     \"Postprandial (reactive) hypoglycemia\", section on 'Postprandial syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/11/20665?source=see_link\">",
"     \"Overview of palpitations in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/0/32776?source=see_link\">",
"     \"Generalized anxiety disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/60/14279?source=see_link\">",
"     \"Overview of the clinical manifestations of hyperthyroidism in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypoglycemia may be classified as insulin-mediated or non-insulin-mediated, or fasting or postprandial. The insulin-based classification deals with pathogenesis but not cause. The latter classification has outlived its usefulness, because hypoglycemic disorders once thought to cause exclusively postprandial or fasting hypoglycemia have been observed in some cases to cause hypoglycemia in the alternate state. In a retrospective review of 237 patients with surgically confirmed insulinoma, 21 percent reported both fasting and postprandial symptoms and 6 percent reported only postprandial symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We have found that the most useful classification is one based upon whether the patient appears to be ill or is medicated or is seemingly well [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/1,9\">",
"     1,9",
"    </a>",
"    ]. The major causes of hypoglycemia using this classification are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef78919 \" href=\"mobipreview.htm?17/42/18092\">",
"     table 1",
"    </a>",
"    ). Given documentation of Whipple's triad, detailed evaluation is usually required in a healthy-appearing patient, whereas hypoglycemia may be readily recognized as part of the underlying illness or its treatment in an ill or medicated patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/39/24184?source=see_link&amp;anchor=H2#H2\">",
"     \"Hypoglycemia in adults without diabetes mellitus: Diagnostic approach\", section on 'Candidates for evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hospitalized patients can present unique diagnostic challenges. In them, hypoglycemia, even in those with diabetes, is often multifactorial and iatrogenic. Therefore, it is as important to examine the patient's medical record as it is to talk to and examine the patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     CAUSES OF HYPOGLYCEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drugs are the most common cause of hypoglycemia (",
"    <a class=\"graphic graphic_table graphicRef78919 \" href=\"mobipreview.htm?17/42/18092\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/1\">",
"     1",
"    </a>",
"    ]. Hypoglycemia is common in type 1 diabetes, especially in patients receiving intensive therapy in whom the risk of severe hypoglycemia is increased more than threefold. Less commonly, hypoglycemia may also affect patients with type 2 diabetes who take either insulin secretagogues or insulin.",
"   </p>",
"   <p>",
"    In contrast, hypoglycemia is uncommon in individuals who do not have drug-treated diabetes mellitus. In such patients, hypoglycemia may be caused by a variety of other drugs, including alcohol, and common critical illnesses such as hepatic, renal, or cardiac failure, sepsis, or inanition. It may be due to adrenal insufficiency, an insulinoma, or an IGF-secreting tumor. In addition, hypoglycemia can be factitious, accidental, or even malicious (",
"    <a class=\"graphic graphic_table graphicRef78919 \" href=\"mobipreview.htm?17/42/18092\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The evaluation to determine the cause of hypoglycemia in adults without diabetes is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/39/24184?source=see_link\">",
"     \"Hypoglycemia in adults without diabetes mellitus: Diagnostic approach\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Hypoglycemia in diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exogenous insulin and insulin secretagogue (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/6/29800?source=see_link\">",
"     glyburide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/28/40391?source=see_link\">",
"     glipizide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/39/8823?source=see_link\">",
"     glimepiride",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/25/4503?source=see_link\">",
"     repaglinide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/21/11606?source=see_link\">",
"     nateglinide",
"    </a>",
"    ) stimulated endogenous insulin secretion suppress hepatic (and renal) glucose production and stimulate glucose utilization and, thus, can cause hypoglycemia, particularly in the setting of compromised defenses. Even in the setting of intact defenses, these drugs can cause hypoglycemia when given in sufficient doses. Among the commonly used sulfonylureas, glyburide (glibenclamide) is more often associated with hypoglycemia than glipizide or glimepiride, probably because of the longer duration of action of glyburide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among the drugs used to treat type 2 diabetes early in its course, insulin sensitizers (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    , thiazolidinediones), glucosidase inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and dipeptidyl peptidase IV inhibitors should not cause hypoglycemia. These drugs rely on residual endogenous insulin secretion for efficacy, and insulin secretion should decrease appropriately as plasma glucose concentrations decline into the normal range. This is true even for GLP 1 receptor agonists that stimulate insulin secretion but do so largely only in a glucose dependent fashion. They also suppress glucagon secretion in a glucose dependent fashion. Thus, insulin levels decrease and glucagon levels increase as glucose levels fall to subthreshold concentrations. However, all of these drugs can increase the risk of hypoglycemia when combined with administration of insulin secretagogues or insulin. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/25/38298?source=see_link\">",
"     \"Glucagon-like peptide-1-based therapies for the treatment of type 2 diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Hypoglycemia in patients without diabetes",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to insulin, sulfonylureas, and meglitinides, other drugs, including alcohol, may also cause hypoglycemia. In a systematic review of 448 publications describing drug-induced hypoglycemia (excluding drugs used to treat diabetes and alcohol), 164 different drugs were associated with hypoglycemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/30\">",
"     30",
"    </a>",
"    ]. However, the evidence supporting the majority of the associations was judged to be of very low quality (",
"    <a class=\"graphic graphic_table graphicRef52892 \" href=\"mobipreview.htm?7/27/7612\">",
"     table 2",
"    </a>",
"    ). The drugs most commonly associated with hypoglycemia were quinolones,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/43/22199?source=see_link\">",
"     pentamidine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/46/15080?source=see_link\">",
"     quinine",
"    </a>",
"    , beta blockers, angiotensin-converting enzyme inhibitors, and IGF-1.",
"   </p>",
"   <p>",
"    The possible contribution of drugs in either ill or seemingly well individuals cannot be overemphasized. A thorough review of a patient's medication history is essential. Drug-induced hypoglycemia occurs more frequently in elderly patients with underlying renal or hepatic dysfunction and in those taking glucose lowering medications, particularly insulin or sulfonylureas. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/23/28023?source=see_link&amp;anchor=H14#H14\">",
"     \"Glycemic control and intensive insulin therapy in critical illness\", section on 'Hypoglycemia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ethanol inhibits gluconeogenesis but not glycogenolysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/1,31\">",
"     1,31",
"    </a>",
"    ]. Thus, alcohol-induced hypoglycemia typically follows a several day alcohol binge with limited ingestion of food resulting in hepatic glycogen depletion. Ethanol may not be detectable in blood at the time of presentation. Because gluconeogenesis becomes the sole source of glucose production during prolonged hypoglycemia, alcohol can also contribute to the progression of hypoglycemia in patients with insulin-treated diabetes. Alcohol ingestion is often the cause of, or a contributing factor to, hypoglycemia in an emergency department.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Critical illness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe hypoglycemia can occur during critical illnesses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/1\">",
"     1",
"    </a>",
"    ]. In a retrospective study of hypoglycemia in an adult intensive care unit, independent risk factors for developing hypoglycemia included diabetes, septic shock, renal insufficiency, mechanical ventilation, severity of illness, and treatment with intensive insulin to achieve tight glycemic control [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sepsis is a relatively common cause of hypoglycemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/1,33\">",
"     1,33",
"    </a>",
"    ]. Cytokine accelerated glucose utilization is usually matched by increased glucose production. Hypoglycemia develops when the latter fails to keep pace perhaps because of cytokine induced inhibition of gluconeogenesis in the setting of glycogen depletion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. The mechanism of hypoglycemia in chronic kidney disease is less clear. It likely involves impaired gluconeogenesis, reduced renal clearance of insulin, and reduced renal glucose production. In severe liver failure, gluconeogenesis is also impaired.",
"   </p>",
"   <p>",
"    In tropical countries where malaria is endemic, hypoglycemia can result from malaria, its treatment, or both [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/1,30\">",
"     1,30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/26/5543?source=see_link\">",
"     \"Clinical manifestations of malaria\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Malnourishment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malnutrition can cause hypoglycemia as a result of substrate limitation of gluconeogenesis and glycogenolysis in the setting of glycogen depletion. Hypoglycemia has been reported in patients with anorexia nervosa [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/36,37\">",
"     36,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Cortisol deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypoglycemia can also occur in patients with cortisol deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/1,38\">",
"     1,38",
"    </a>",
"    ]. However, it is not often found in adults in the absence of other clinical clues. Hypoglycemia is more common in infants and children with primary adrenal insufficiency, patients with secondary adrenal insufficiency caused by isolated ACTH deficiency, and patients with type 1 diabetes mellitus who develop adrenal insufficiency. In the latter patients, sensitivity to insulin is increased because of loss of the gluconeogenic effect of cortisol and the hyperglycemic effects of epinephrine. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/60/29638?source=see_link\">",
"     \"Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Nonislet cell tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe hypoglycemia has been observed in a small number of patients with nonislet cell tumors, usually large tumors of mesenchymal or epithelial cell types. Hypoglycemia usually occurs as a result of tumor production of incompletely processed IGF-II [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/1\">",
"     1",
"    </a>",
"    ]. Endogenous production of insulin is appropriately suppressed. The pathophysiology, diagnosis, and treatment of nonislet cell tumor hypoglycemia are reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/12/11461?source=see_link\">",
"     \"Nonislet cell tumor hypoglycemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Endogenous hyperinsulinism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperinsulinemic hypoglycemia occurs when there is a failure of insulin secretion to fall to very low rates as plasma glucose concentrations fall to hypoglycemic levels; hypoglycemia is the result of low rates of glucose production rather than high rates of glucose utilization.",
"   </p>",
"   <p>",
"    Endogenous hyperinsulinism is more likely in an otherwise overtly well individual with no clinical clues to the common causes of hypoglycemia. In adults, hypoglycemia due to endogenous hyperinsulinism can be caused by the following (",
"    <a class=\"graphic graphic_table graphicRef78919 \" href=\"mobipreview.htm?17/42/18092\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A beta cell secretagogue, such as a sulfonylurea (see",
"      <a class=\"local\" href=\"#H21\">",
"       'Accidental, surreptitious, or malicious hypoglycemia'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      A beta cell tumor (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/30/12777?source=see_link\">",
"       \"Insulinoma\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      A functional beta cell disorder, often termed nesidioblastosis, that can occur as a feature of the noninsulinoma pancreatogenous hypoglycemia syndrome (NIPHS) or of post-gastric bypass hypoglycemia (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/36/44614?source=see_link\">",
"       \"Noninsulinoma pancreatogenous hypoglycemia syndrome\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Insulin autoimmune hypoglycemia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Insulin autoimmune hypoglycemia occurs in patients who have antibodies directed to endogenous insulin or to the insulin receptor. Symptoms can occur postprandially, fasting, or in both states. In patients with insulin autoantibodies, insulin secreted in response to a meal binds to the antibody and then disassociates in an unregulated fashion causing hyperinsulinemia and hypoglycemia. In patients with antibodies to the insulin receptor, who usually have preexistent insulin-treated diabetes, hypoglycemia occurs as a result of antibody activation of the receptor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Persistent hyperinsulinemic hypoglycemia of infancy (PHHI) or congenital hyperinsulinism is the most common cause of persistent hypoglycemia in infancy. PHHI is a genetic disorder with both familial and sporadic forms, characterized by dysregulation of insulin secretion. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/49/3866?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of persistent hyperinsulinemic hypoglycemia of infancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Accidental, surreptitious, or malicious hypoglycemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The possibility of accidental, surreptitious, or even malicious hypoglycemia should be considered when the cause of a hypoglycemic disorder is not apparent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44664/abstract/1\">",
"     1",
"    </a>",
"    ]. Hypoglycemia can result from medical, pharmacy, or patient errors, such as the mistaken use of a hypoglycemic tablet by the elderly spouse of a patient with diabetes. It may also occur after ingestion of herbal products contaminated with sulfonylureas or after covert self-administration of a hypoglycemic tablet or insulin by a patient with or without diabetes. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/32/18951?source=see_link\">",
"     \"Factitious hypoglycemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Covert use of a glucose lowering medication, often a sulfonylurea, occurs more commonly in a person who is knowledgeable about how the drug works and who has access to it. Malicious hypoglycemia involves administration of an insulin secretogogue or insulin to another person with the intent to cause hypoglycemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?14/12/14531?source=see_link\">",
"       \"Patient information: Low blood sugar in people with diabetes (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although hypoglycemia occurs often in patients with type 1 diabetes and in some patients with type 2 diabetes treated with an insulin secretagogue or insulin, it is uncommon in patients without diabetes. (See",
"      <a class=\"local\" href=\"#H28642693\">",
"       'Epidemiology'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/63/27641?source=see_link\">",
"       \"Management of hypoglycemia during treatment of diabetes mellitus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The symptoms of hypoglycemia in patients with and without diabetes are nonspecific and may include tremor, palpitations, sweating, hunger, paresthesias, cognitive impairment, behavioral changes, and psychomotor abnormalities. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with diabetes, hypoglycemia is defined as all episodes of an abnormally low plasma glucose concentration (with or without symptoms) that expose the individual to harm. In patients with insulin secretogogue or insulin-treated diabetes, defensive actions to prevent hypoglycemia are initiated when self-monitoring shows a blood glucose &lt;70",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (3.9",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Patients with diabetes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the patient without diabetes, the definition of hypoglycemia is based upon the presence of Whipple's triad: symptoms, signs, or both consistent with hypoglycemia, a low plasma glucose concentration at the time of symptoms, and resolution of those signs and symptoms after raising the plasma glucose concentration. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Patients without diabetes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In individuals without diabetes but with concomitant illness, hypoglycemia is most often due to a drug (",
"      <a class=\"graphic graphic_table graphicRef52892 \" href=\"mobipreview.htm?7/27/7612\">",
"       table 2",
"      </a>",
"      ). Less common causes include critical illness, endocrine deficiency, or a nonislet cell tumor. Endogenous hyperinsulinism or accidental, surreptitious, or malicious hypoglycemia are more likely in the well-appearing patient (",
"      <a class=\"graphic graphic_table graphicRef78919 \" href=\"mobipreview.htm?17/42/18092\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Causes of hypoglycemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The evaluation of nondiabetic patients with hypoglycemia is discussed elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/39/24184?source=see_link\">",
"       \"Hypoglycemia in adults without diabetes mellitus: Diagnostic approach\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/1\">",
"      Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2009; 94:709.",
"     </a>",
"    </li>",
"    <li>",
"     Cryer PE. Hypoglycemia in diabetes: Pathophysiology, prevalence, and prevention, 2nd, American Diabetes Association, Alexandria, VA 2012.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/3\">",
"      UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007; 50:1140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/4\">",
"      Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008; 57:3169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/5\">",
"      Donnelly LA, Morris AD, Frier BM, et al. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet Med 2005; 22:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/6\">",
"      Holstein A, Plaschke A, Egberts EH. Clinical characterisation of severe hypoglycaemia--a prospective population-based study. Exp Clin Endocrinol Diabetes 2003; 111:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/7\">",
"      Leese GP, Wang J, Broomhall J, et al. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 2003; 26:1176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/8\">",
"      Service FJ. Hypoglycemic disorders. N Engl J Med 1995; 332:1144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/9\">",
"      Service FJ. Classification of hypoglycemic disorders. Endocrinol Metab Clin North Am 1999; 28:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/10\">",
"      Nirantharakumar K, Marshall T, Hodson J, et al. Hypoglycemia in non-diabetic in-patients: clinical or criminal? PLoS One 2012; 7:e40384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/11\">",
"      Hepburn DA, Deary IJ, Frier BM, et al. Symptoms of acute insulin-induced hypoglycemia in humans with and without IDDM. Factor-analysis approach. Diabetes Care 1991; 14:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/12\">",
"      Towler DA, Havlin CE, Craft S, Cryer P. Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 1993; 42:1791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/13\">",
"      DeRosa MA, Cryer PE. Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation. Am J Physiol Endocrinol Metab 2004; 287:E32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/14\">",
"      Cryer PE. Hypoglycemia, functional brain failure, and brain death. J Clin Invest 2007; 117:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/15\">",
"      Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 1988; 37:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/16\">",
"      Mitrakou A, Fanelli C, Veneman T, et al. Reversibility of unawareness of hypoglycemia in patients with insulinomas. N Engl J Med 1993; 329:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/17\">",
"      Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005; 28:1245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/18\">",
"      Frier BM. Defining hypoglycaemia: what level has clinical relevance? Diabetologia 2009; 52:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/19\">",
"      Swinnen SG, Mullins P, Miller M, et al. Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia. Diabetologia 2009; 52:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/20\">",
"      Amiel SA, Dixon T, Mann R, Jameson K. Hypoglycaemia in Type 2 diabetes. Diabet Med 2008; 25:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/21\">",
"      Cryer PE. Preventing hypoglycaemia: what is the appropriate glucose alert value? Diabetologia 2009; 52:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/22\">",
"      Whipple, AO. The surgical therapy of hyperinsulinism. J Int Chir 1938; 3:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/23\">",
"      Consensus statement on self-monitoring of blood glucose. Diabetes Care 1987; 10:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/24\">",
"      Gambino R, Piscitelli J, Ackattupathil TA, et al. Acidification of blood is superior to sodium fluoride alone as an inhibitor of glycolysis. Clin Chem 2009; 55:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/25\">",
"      Goodenow TJ, Malarkey WB. Leukocytosis and artifactual hypoglycemia. JAMA 1977; 237:1961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/26\">",
"      Macaron CI, Kadri A, Macaron Z. Nucleated red blood cells and artifactual hypoglycemia. Diabetes Care 1981; 4:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/27\">",
"      Theofilogiannakos EK, Giannakoulas G, Ziakas A, et al. Pseudohypoglycemia in a patient with the Eisenmenger syndrome. Ann Intern Med 2010; 152:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/28\">",
"      Placzkowski KA, Vella A, Thompson GB, et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J Clin Endocrinol Metab 2009; 94:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/29\">",
"      Szoke E, Gosmanov NR, Sinkin JC, et al. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia. Metabolism 2006; 55:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/30\">",
"      Murad MH, Coto-Yglesias F, Wang AT, et al. Clinical review: Drug-induced hypoglycemia: a systematic review. J Clin Endocrinol Metab 2009; 94:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/31\">",
"      Marks V, Teale JD. Drug-induced hypoglycemia. Endocrinol Metab Clin North Am 1999; 28:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/32\">",
"      Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007; 35:2262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/33\">",
"      Miller SI, Wallace RJ Jr, Musher DM, et al. Hypoglycemia as a manifestation of sepsis. Am J Med 1980; 68:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/34\">",
"      Maitra SR, Wojnar MM, Lang CH. Alterations in tissue glucose uptake during the hyperglycemic and hypoglycemic phases of sepsis. Shock 2000; 13:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/35\">",
"      Metzger S, Nusair S, Planer D, et al. Inhibition of hepatic gluconeogenesis and enhanced glucose uptake contribute to the development of hypoglycemia in mice bearing interleukin-1beta- secreting tumor. Endocrinology 2004; 145:5150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/36\">",
"      Rich LM, Caine MR, Findling JW, Shaker JL. Hypoglycemic coma in anorexia nervosa. Case report and review of the literature. Arch Intern Med 1990; 150:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/37\">",
"      Yanai H, Yoshida H, Tomono Y, Tada N. Severe hypoglycemia in a patient with anorexia nervosa. Eat Weight Disord 2008; 13:e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/38\">",
"      Yamamoto T, Fukuyama J, Hasegawa K, Sugiura M. Isolated corticotropin deficiency in adults. Report of 10 cases and review of literature. Arch Intern Med 1992; 152:1705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44664/abstract/39\">",
"      Lupsa BC, Chong AY, Cochran EK, et al. Autoimmune forms of hypoglycemia. Medicine (Baltimore) 2009; 88:141.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1763 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-77.94.48.4-CE85A84A2F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_39_44664=[""].join("\n");
var outline_f43_39_44664=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28642693\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11376092\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Patients with diabetes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Patients without diabetes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18546202\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      CAUSES OF HYPOGLYCEMIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Hypoglycemia in diabetes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Hypoglycemia in patients without diabetes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Critical illness",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Malnourishment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Cortisol deficiency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Nonislet cell tumors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Endogenous hyperinsulinism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Accidental, surreptitious, or malicious hypoglycemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/1763\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/1763|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/42/18092\" title=\"table 1\">",
"      Causes hypoglycemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/27/7612\" title=\"table 2\">",
"      Drugs that cause hypoglycemia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/60/29641?source=related_link\">",
"      Blood glucose self-monitoring in management of adults with diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/26/5543?source=related_link\">",
"      Clinical manifestations of malaria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/32/18951?source=related_link\">",
"      Factitious hypoglycemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/0/32776?source=related_link\">",
"      Generalized anxiety disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/25/38298?source=related_link\">",
"      Glucagon-like peptide-1-based therapies for the treatment of type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/23/28023?source=related_link\">",
"      Glycemic control and intensive insulin therapy in critical illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/39/24184?source=related_link\">",
"      Hypoglycemia in adults without diabetes mellitus: Diagnostic approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/30/12777?source=related_link\">",
"      Insulinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/63/27641?source=related_link\">",
"      Management of hypoglycemia during treatment of diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/36/44614?source=related_link\">",
"      Noninsulinoma pancreatogenous hypoglycemia syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/12/11461?source=related_link\">",
"      Nonislet cell tumor hypoglycemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/11/20665?source=related_link\">",
"      Overview of palpitations in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/60/14279?source=related_link\">",
"      Overview of the clinical manifestations of hyperthyroidism in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/49/3866?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of persistent hyperinsulinemic hypoglycemia of infancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?14/12/14531?source=related_link\">",
"      Patient information: Low blood sugar in people with diabetes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/60/29638?source=related_link\">",
"      Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/11/3255?source=related_link\">",
"      Postprandial (reactive) hypoglycemia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_39_44665="Epidemiology; pathogenesis; clinical features; and complications of infantile hemangiomas";
var content_f43_39_44665=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology; pathogenesis; clinical features; and complications of infantile hemangiomas",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/39/44665/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/39/44665/contributors\">",
"     Denise W Metry, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/39/44665/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/39/44665/contributors\">",
"     Moise L Levy, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/39/44665/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/39/44665/contributors\">",
"     Rosamaria Corona, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/39/44665/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vascular lesions of infants and children are classified into two major types: tumors and vascular malformations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/1\">",
"     1",
"    </a>",
"    ]. Infantile hemangiomas are the most common vascular tumors. Other examples of vascular tumors include: pyogenic granuloma, kaposiform hemangioendothelioma, and tufted angioma. So-called rapidly involuting (RICH) and non-involuting (NICH) \"congenital\" hemangiomas appear histopathologically to be hybrids showing features of both vascular tumor and malformation. Because cases of RICH evolving into NICH have been reported, it has been suggested that these two entities lie within the same spectrum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Infantile hemangiomas are characterized by a growth phase and an involution phase. In contrast, vascular malformations, which are structural anomalies derived from capillaries, arteries, veins, lymphatics, or a combination thereof, grow in proportion to the child but generally do not regress. Vascular malformations are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/21/30038?source=see_link\">",
"     \"Vascular lesions in the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite their benign and self-limited nature, some hemangiomas can cause complications such as ulceration and permanent disfigurement. In addition, some may compromise vital organ function or herald underlying developmental anomalies of the spine, central nervous system, circulatory system,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    eyes. Hemangiomas in the liver, brain, or gastrointestinal tract may rarely cause life-threatening complications. Large size, facial location,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    segmental morphology are the most common predictors of poor short-term outcomes as measured by complication and treatment rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Segmental lesions'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    An overview of the epidemiology, pathogenesis, clinical features, and complications of infantile hemangiomas will be presented here. The evaluation and management are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/23/5495?source=see_link\">",
"     \"Evaluation and diagnosis of infantile hemangiomas\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/60/25546?source=see_link\">",
"     \"Management of infantile hemangiomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemangiomas are the most common tumors of infancy. The true incidence of infantile hemangiomas is unknown [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/5\">",
"     5",
"    </a>",
"    ]. Although they are classically said to occur in up to 10 percent of Caucasian infants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/6,7\">",
"     6,7",
"    </a>",
"    ], 4 to 5 percent is probably a better estimate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/5\">",
"     5",
"    </a>",
"    ]. Infantile hemangiomas are generally noticed within the first few days to months of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Although most hemangiomas occur sporadically, familial transmission in an autosomal dominant fashion has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hemangiomas are two to three times more common among females than males [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/11-13\">",
"       11-13",
"      </a>",
"      ]. Complicated hemangiomas are even more likely to occur among female infants, for reasons that are unknown [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hemangiomas are more common among white non-Hispanic infants than other racial groups [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/6,13,15\">",
"       6,13,15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The incidence of hemangiomas is increased in preterm infants [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/13\">",
"       13",
"      </a>",
"      ]; the most significant risk factor appears to be low birth weight.",
"     </li>",
"     <li>",
"      Multiple hemangiomas more commonly occur in products of multiple gestations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Prenatal associations include older maternal age, placenta previa, and pre-eclampsia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Chorionic villus sampling does not appear to play a significant role in the formation of most hemangiomas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemangiomas are characterized by phases of proliferation and involution as defined by a rapid proliferation of blood vessels in the first year of life, followed by gradual regression of the vascular component with replacement by fibrofatty tissue. The exact mechanisms that govern these processes are incompletely understood but are beginning to be elucidated.",
"   </p>",
"   <p>",
"    Glucose transporter isoform 1 (GLUT1), and placenta-associated vascular antigens (Fc-gamma-receptor II, merosin, and Lewis Y antigen) are highly expressed in the endothelial cells of infantile hemangiomas during both the proliferative and involution phase [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. These markers are not expressed in normal dermal or subcutaneous capillaries, nor are they expressed in other types of vascular tumors. The only other vasculature known to share this constellation of markers is that of placental chorionic villi. The gene expression profiles of hemangiomas and placenta are very similar compared to other tissue, suggesting that they share a common genetic program [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/19\">",
"     19",
"    </a>",
"    ]. However, the precise relationship between infantile hemangiomas and chorionic villi has yet to be explained.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Proliferation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although biopsy of hemangiomas is not routinely necessary because the diagnosis can generally be made clinically, histologic examination during the proliferation stage demonstrates superficial proliferating angioblastic endothelial cells with few capillary lumina [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Current evidence suggests that hemangiomas are clonal proliferations of endothelial cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/21,22\">",
"     21,22",
"    </a>",
"    ], resulting from vasculogenesis (the formation of primitive blood vessels from angioblasts), rather than angiogenesis (the growth of new vessels from pre-existing vessels) as traditionally thought [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/23\">",
"     23",
"    </a>",
"    ]. This hypothesis is supported by a study in which implantation of multipotential stem cells from human hemangioma tissue (isolated based on expression of CD133, a stem cell population marker) gave rise to hemangioma-like lesions in immunodeficient mice that spontaneously regressed, similar to what occurs in infantile hemangiomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, proliferating hemangiomas contain hematopoietic leukocytes of myeloid origin that may play a role in hemangioma growth. Hemangioma endothelial cell coexpression of myeloid markers CD83, CD32, CD14, and CD15 supports the concept that hemangioma endothelium is distinct from that of normal vasculature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hemangioma proliferation appears to result from an imbalance between positive and negative vasculogenic factors expressed by the hemangioma and adjacent normal tissue [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/26\">",
"     26",
"    </a>",
"    ]. This is supported by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increased expression of endothelial cell markers (eg, CD34 and CD31), primitive cell population markers (eg, CD133 and LYVE-1 [a marker for lymphatic vessels]), insulin-like growth factor 2, and certain integrins in proliferating hemangiomas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/27-30\">",
"       27-30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Overexpression of basic fibroblast growth factor (bFGF, FGF 2), vascular endothelial growth factor (VEGF), proliferating cell nuclear antigen, and type IV collagenase in proliferating hemangiomas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/26,31,32\">",
"       26,31,32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Infantile hemangioma has suppressed VEGFR1 expression, but constitutive VEGFR2 signaling, an effect mediated by nuclear factor of activated T cells (NFAT), and mutations in VEGFR2 or the integrin-ike receptor TEM-8 have been found in some individuals with hemangiomas that inhibit the activity of NFAT pathway [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Imbalance of two VEGF receptor tyrosine kinases (VEGFR1 and VEGFR2) affected availability of VEGF and endothelial cell proliferation in hemangioma-derived endothelial cells (",
"      <a class=\"graphic graphic_figure graphicRef64171 \" href=\"mobipreview.htm?27/4/27716\">",
"       figure 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/33,34\">",
"       33,34",
"      </a>",
"      ]. Treatment of the cell lines with VEGF neutralizing antibodies normalized the VEGF signaling profile.",
"     </li>",
"     <li>",
"      Increased quantities of bFGF and matrix metalloproteinases in the urine of patients with proliferating hemangiomas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/31,35\">",
"       31,35",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Involution",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spontaneous involution phase typically begins in the latter part of the first year and continues over a variable number of years. Involution is characterized by histologic fibrosis of capillary lumina. Increased apoptosis during the second year appears to counteract proliferation and may be involved in initiating involution [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/36\">",
"     36",
"    </a>",
"    ]. This is supported by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increased numbers of mast cells and levels of tissue metalloproteinase (an inhibitor of new blood vessel formation) in involuting hemangiomas.",
"     </li>",
"     <li>",
"      Upregulation of interferon-induced genes in involuting hemangiomas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Decreased quantities of bFGF in the urine of patients with involuting hemangiomas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/31,37\">",
"       31,37",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of hemangiomas are not clinically evident at birth but become apparent within the first days to months of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/12,38\">",
"     12,38",
"    </a>",
"    ]. Some newborns have a premonitory cutaneous mark, such as a patch of telangiectasias with surrounding pallor (secondary to vasoconstriction) at the hemangioma site. Early lesions may be so subtle as to go unrecognized and may be mistaken for a scratch or bruise. Less commonly, a hemangioma may appear initially as a bright red patch resembling a port-wine stain.",
"   </p>",
"   <p>",
"    The majority of lesions are solitary, but multiple lesions occur in up to 20 percent of infants and are especially common among multiple births [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/12\">",
"     12",
"    </a>",
"    ]. Hemangiomas have a predilection for the head and neck, although they can occur anywhere in the skin, mucous membranes, or internal organs. Hemangiomas range in size from a few millimeters to many centimeters in diameter. They may be superficial, deep, or combined (compound hemangioma).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The superficial presentation is most common [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/39\">",
"       39",
"      </a>",
"      ] and consists of a bright red papule, nodule, or plaque raised above clinically normal skin (",
"      <a class=\"graphic graphic_picture graphicRef60004 \" href=\"mobipreview.htm?11/7/11390\">",
"       picture 1",
"      </a>",
"      ). Superficial hemangiomas have been called \"strawberry\" or \"capillary\" hemangiomas, but superficial hemangioma is the preferred term [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/40\">",
"       40",
"      </a>",
"      ], since not all superficial hemangiomas have the \"strawberry\" appearance, and not all strawberry-like lesions are hemangiomas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/41,42\">",
"       41,42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The deep, or subcutaneous, hemangioma is typically a raised, skin-colored nodule, which often has a bluish hue with or without central telangiectatic patch (",
"      <a class=\"graphic graphic_picture graphicRef50388 \" href=\"mobipreview.htm?27/60/28623\">",
"       picture 2",
"      </a>",
"      ). Purely deep hemangiomas are less common [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/39\">",
"       39",
"      </a>",
"      ]. They have been called \"cavernous\" hemangiomas, a term that is also erroneously used to describe venous malformations and thus is best avoided.",
"     </li>",
"     <li>",
"      Combined hemangiomas are fairly common and contain both superficial and deep components [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Natural history",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5833753\">",
"    <span class=\"h3\">",
"     Proliferation and involution",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemangiomas characteristically undergo a growth (proliferative) phase that is generally rapid for the first several months. Slow proliferation can continue for the first 6 to 12 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. Proliferation after the first year can occur but is uncommon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/2,44\">",
"     2,44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The growth characteristics of 526 infantile hemangiomas were described in a multicenter, longitudinal, cohort study of 433 children who were followed by pediatric dermatologists in tertiary care centers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/44\">",
"     44",
"    </a>",
"    ]. In this referral population:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      80 percent of hemangioma size was reached during the early proliferative stage, at a mean age of three months. Most hemangioma growth occurs before five months.",
"     </li>",
"     <li>",
"      The late proliferative stage (ongoing, but less rapid growth) was usually complete by nine months of age; only 3 percent of lesions had documented growth after nine months of age. Deep hemangiomas tended to grow later and longer than superficial hemangiomas.",
"     </li>",
"     <li>",
"      Hemangiomas proliferated within a defined anatomic area; increased volume was achieved without centrifugal spread.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a small prospective study including 30 infants, serial images were analyzed to evaluate the hemangioma growth rate. Photographs were taken at intervals of one to two weeks starting one to two weeks after birth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/45\">",
"     45",
"    </a>",
"    ]. The study found that hemangioma growth is nonlinear and that the most rapid growth takes place between 5.5 and 7.5 weeks of age. &nbsp;",
"   </p>",
"   <p>",
"    The proliferative phase is followed by a spontaneous involution phase that typically begins after one year and lasts a variable number of years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/44\">",
"     44",
"    </a>",
"    ]. Superficial hemangiomas typically enter the involution stage earlier than deep hemangiomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The first clinical sign of involution within a superficial hemangioma is a color change from bright red to dark or violaceous red to gray, which often begins centrally as the tumor softens and flattens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/12,44\">",
"     12,44",
"    </a>",
"    ]. An early white discoloration of the hemangioma surface occurring in infants younger than three months may herald ulceration, not involution [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/46\">",
"     46",
"    </a>",
"    ]. Deep lesions become less blue and warm. The rate and extent of hemangioma involution varies among affected children and may be proportional to size, with larger lesions exhibiting longer periods of growth and involution and smaller lesions shorter periods of growth and involution [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Completed involution occurs at an estimated minimum rate of 10 percent per year, so approximately 50 percent of hemangiomas have involuted by age five years, 70 percent by age seven, and 90 percent by age nine. However, the rate of involution is highly variable. It also must be emphasized that in many cases, complete involution does not result in normal-appearing skin. Up to one-half of children with hemangiomas experience residual changes such as scarring, atrophy, redundant skin, discoloration, and telangiectasias. Clinicians who evaluate children who have hemangiomas should be realistic with parents about the potential outcomes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Superficial, very raised hemangiomas, especially those that exhibit a sharp, 'cliff-like' border (",
"      <a class=\"graphic graphic_picture graphicRef61868 \" href=\"mobipreview.htm?39/31/40434\">",
"       picture 3",
"      </a>",
"      ) , or pedunculated lesions (hemangiomas extending from a smaller base) are at risk for residual fibrofatty tissue, which may ultimately require surgical intervention.",
"     </li>",
"     <li>",
"      Hemangiomas of the lip that cross the vermillion border (",
"      <a class=\"graphic graphic_picture graphicRef60003 \" href=\"mobipreview.htm?0/32/512\">",
"       picture 4",
"      </a>",
"      ) and large tumors of the nose (\"Cyrano nose\") and auricle are more prone to disfigurement.",
"     </li>",
"     <li>",
"      Large tumor or plaque-like lesions, especially when rapidly proliferating",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      in trauma-prone locations, show a tendency toward ulceration, which invariably leads to scarring.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3163479\">",
"    <span class=\"h3\">",
"     Infantile hemangiomas with minimal or arrested growth",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a minority of cases, hemangiomas fail to proliferate beyond the telangiectatic patch associated with the premonitory stage or only a small portion of the lesion proliferates (",
"    <a class=\"graphic graphic_picture graphicRef65721 \" href=\"mobipreview.htm?19/60/20416\">",
"     picture 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/47\">",
"     47",
"    </a>",
"    ]. The majority of these hemangiomas occur on the lower body.",
"   </p>",
"   <p>",
"    Infantile hemangiomas with minimal or arrested growth are often confused with port-wine stains; a blotchy red-blue patch with perilesional blanching and both fine and coarse telangiectasias suggests a diagnosis of hemangioma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/47\">",
"     47",
"    </a>",
"    ]. A small proliferative component, often at the lesion periphery, is another useful diagnostic clue. However, a proliferative component is present in less than one-third of cases.",
"   </p>",
"   <p>",
"    Additional studies are necessary to determine the natural history of this variant.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Localized lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemangioma morphology provides an important clue to potential complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/11\">",
"     11",
"    </a>",
"    ]. Hemangiomas can be categorized as localized (or focal), segmental, or multiple. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Complications'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Localized hemangiomas, which constitute the majority of lesions, demonstrate clear, well-defined spatial containment, appear to arise from a single focus, and lack evidence of a linear or geometric pattern. Localized hemangiomas of the face appear to occur near lines of mesenchymal or mesenchymal-ectodermal embryonic fusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Segmental lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Segmental hemangiomas are usually patch or plaque-like and demonstrate a linear",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    geographic presence over a specific cutaneous territory that is currently under investigation (",
"    <a class=\"graphic graphic_picture graphicRef82212 \" href=\"mobipreview.htm?16/51/17200\">",
"     picture 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/11,48\">",
"     11,48",
"    </a>",
"    ]. In one study, photographs of 165 patients with segmental or indeterminate hemangiomas were analyzed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/48\">",
"     48",
"    </a>",
"    ]. Four distinct patterns of involvement were identified (segments 1 to 4). Segments 2 and 3 corresponded to the maxillary and mandibular previously described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/49\">",
"     49",
"    </a>",
"    ]. However, segment 1 involves the lateral forehead, anterior temporal scalp, and lateral frontal scalp, and segment 4 involves the medial frontal scalp, nose, and philtrum. These observations suggest that neural crest derivatives may be involved in facial hemangioma development.",
"   </p>",
"   <p>",
"    Segmental hemangiomas are more likely to occur among female infants and, compared to localized lesions, are much more likely to be associated with complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/11,50\">",
"     11,50",
"    </a>",
"    ]. Children with segmental hemangiomas generally require more intensive and prolonged therapy and have a poorer overall outcome than children with hemangiomas of localized morphology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     PHACE syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;PHACE syndrome (MIM 606519) is defined by the presence of a large, segmental hemangioma, usually on the face or head, in association with one or more congenital malformations, most commonly structural or cerebrovascular anomalies of the brain (",
"    <a class=\"graphic graphic_table graphicRef80245 \" href=\"mobipreview.htm?9/52/10059\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/51-53\">",
"     51-53",
"    </a>",
"    ]. The syndrome represents a spectrum of disease, with few infants manifesting the entire constellation of anomalies. An expert panel met to develop consensus criteria for PHACE syndrome and possible PHACE syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/53\">",
"     53",
"    </a>",
"    ]. Diagnosis of PHACE requires clinical examination of the skin and eyes, as well as imaging of the head, neck, and chest [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    PHACE is not rare; one study suggests that it may be as common, or perhaps even more common, than Sturge-Weber syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/54\">",
"     54",
"    </a>",
"    ]. It is more common among girls than boys, with an 8 to 9:1 ratio [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/50\">",
"     50",
"    </a>",
"    ]. Most cases occur in full-term, normal-birth-weight, singleton infants. This is in contrast to non-PHACE hemangiomas, which have an increased incidence in preterm, low-birth-weight infants and in products of multiple gestations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Epidemiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In addition to the varied spectrum, the general ipsilateral relationship between the cutaneous hemangioma and associated anomalies in patients with PHACE suggests a defect involved in lateralization or \"developmental field defect\", which implies that certain insults of embryonic development at a specific critical time may give rise to very similar developmental outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/50,55\">",
"     50,55",
"    </a>",
"    ]. The type of structural anomalies found in association with PHACE suggests that the timing of these errors in morphogenesis occurs early, probably between 3 and 12 weeks of gestation, prior to or during early vasculogenesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The hallmark of PHACE syndrome, a large, segmental hemangioma, usually on the face, may involve one to several facial dermatomes (",
"    <a class=\"graphic graphic_picture graphicRef70599 \" href=\"mobipreview.htm?18/46/19174\">",
"     picture 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/52,57\">",
"     52,57",
"    </a>",
"    ]. In one prospective study of 108 infants with large facial hemangiomas (&ge;22 cm",
"    <sup>",
"     2",
"    </sup>",
"    ), 33 (31%) had PHACE syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/58\">",
"     58",
"    </a>",
"    ]. An early presentation may be mistaken for the port wine stain associated with the Sturge-Weber syndrome. However, a port wine stain is a vascular malformation that, unlike infantile hemangioma, does not proliferate in infancy or regress.",
"   </p>",
"   <p>",
"    Cerebral vascular anomalies appear to be the most common extracutaneous manifestation of PHACE. Structural and cerebrovascular brain malformations occur in the vast majority of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/50\">",
"     50",
"    </a>",
"    ]. Posterior fossa malformations, including the Dandy-Walker complex, cerebellar hypoplasia or atrophy,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <span class=\"nowrap\">",
"     dysgenesis/agenesis",
"    </span>",
"    of the vermis, are the most common structural brain anomalies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/54,59,60\">",
"     54,59,60",
"    </a>",
"    ]. These structural anomalies may be associated with developmental delays, particularly motor delays, and pituitary dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/61\">",
"     61",
"    </a>",
"    ]. The cerebrovascular anomalies, especially carotid artery anomalies, are of particular concern because of reports of progressive arterial occlusion, stroke, and other neurologic complications during infancy and childhood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/56,62-65\">",
"     56,62-65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cardiac anomalies are the second most common extracutaneous manifestation of PHACE, and include coarctation of the aorta, complex aortic arch anomalies, and ventricular and atrial septal defects, among others [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/51,57\">",
"     51,57",
"    </a>",
"    ]. The aortic coarctation observed in PHACE differs from classic coarctation in that it is more proximal (often involving the arteries feeding the upper extremities) and involves longer segments, which may preclude detection based upon a blood pressure gradient between the upper and lower extremities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ophthalmologic anomalies include microphthalmos, retinal vascular abnormalities or persistent fetal retinal vessels, optic nerve atrophy, iris hypertrophy or hypoplasia, exophthalmos, colobomas (fissure or cleft of the iris, ciliary body, or choroid), and excavated optic disc anomalies (including \"morning glory\"), among others [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/66\">",
"     66",
"    </a>",
"    ]. (See appropriate topic reviews).",
"   </p>",
"   <p>",
"    Ventral developmental defects include sternal clefting (ranging from a sternal pit, without underlying soft tissue or bony loss, to complete separation of the sternal bars) or the presence of a supraumbilical raphe, which resembles a well-healed scar extending superiorly from the umbilicus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Endocrinologic abnormalities have been reported in a small number of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/61\">",
"     61",
"    </a>",
"    ]. The endocrine abnormalities can be easily overlooked, and a low threshold of suspicion must be maintained [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hearing loss (conductive or sensorineural) also has been reported in patients with PHACE syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/67\">",
"     67",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/23/5495?source=see_link&amp;anchor=H13165020#H13165020\">",
"     \"Evaluation and diagnosis of infantile hemangiomas\", section on 'PHACE syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A PHACE registry has been established to promote further understanding of this disorder. Information about the registry may be found on the Texas Children's Hospital Dermatology Web site (",
"    <a class=\"external\" href=\"file://www.texaschildrenshospital.org/Locate/Departments-and-Services/Dermatology/\">",
"     file://www.texaschildrenshospital.org/Locate/Departments-and-Services/Dermatology/",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Lumbosacral lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemangiomas located over the lumbar or sacral spine may be associated with myelopathy, spinal bony",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    genitourinary or anorectal anomalies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/68-72\">",
"     68-72",
"    </a>",
"    ]. Segmental lesions that span the midline are of greatest concern (",
"    <a class=\"graphic graphic_picture graphicRef72298 \" href=\"mobipreview.htm?17/3/17471\">",
"     picture 8",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The evaluation of children with these lesions is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/23/5495?source=see_link\">",
"     \"Evaluation and diagnosis of infantile hemangiomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Other associations",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to PHACE syndrome, spinal dysraphism, and genitourinary anomalies, solitary, segmental hemangiomas of the skin may be associated with visceral hemangiomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Multiple lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most children with multiple hemangiomas (arbitrarily defined as &ge;5 generally small, localized hemangiomas), the hemangiomas are limited to the skin, and the condition is benign (benign neonatal hemangiomatosis). Visceral hemangiomas that cause life-threatening complications (also known as diffuse neonatal hemangiomatosis) appear to be relatively rare.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Visceral hemangiomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multifocal hepatic hemangiomas most commonly occur in the presence of multiple skin hemangiomas and are probably most often asymptomatic, in which case they can be managed with observation with or without serial imaging.",
"   </p>",
"   <p>",
"    Rarely, multifocal hepatic hemangiomas can have large vessel shunts that result in heart failure, which can be treated with pharmacotherapy or embolization if necessary. Diffuse liver hemangiomas, which may occur in the absence of skin hemangiomas, cause massive hepatomegaly with abdominal compartment syndrome, impaired ventilation, impaired venous return, and renal vein compression, and are associated with a high mortality rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other potential complications of visceral hemangiomas, dependent on specific organ involvement, include gastrointestinal hemorrhage, obstructive jaundice, and central nervous system sequelae due to mass effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/76-78\">",
"     76-78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most cutaneous hemangiomas are uncomplicated and require no intervention. However, some lesions may ulcerate, leading to pain, bleeding, scarring,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    infection. Other lesions may cause functional impairment during,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    disfigurement after, the proliferative phase (",
"    <a class=\"graphic graphic_table graphicRef50196 \" href=\"mobipreview.htm?33/24/34187\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Ulceration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ulceration is the most common complication of hemangiomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/13\">",
"     13",
"    </a>",
"    ]. In a prospective cohort of 1096 children (&lt;12 years) with infantile hemangiomas, ulceration occurred in approximately 16 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/79\">",
"     79",
"    </a>",
"    ]. It is particularly frequent when hemangiomas are rapidly proliferating and located in trauma- or pressure-prone locations (",
"    <a class=\"graphic graphic_picture graphicRef74768 \" href=\"mobipreview.htm?11/51/12095\">",
"     picture 9",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef68162 \" href=\"mobipreview.htm?23/52/24384\">",
"     picture 10",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/79\">",
"     79",
"    </a>",
"    ]. An early white discoloration of the hemangioma surface in infants younger than three months may herald ulceration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/46\">",
"     46",
"    </a>",
"    ]. The cause of ulcer formation is unknown, but given the typical locations, maceration and frictional stress are probable contributing factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/80\">",
"     80",
"    </a>",
"    ]. Ulceration is often painful and may lead to bleeding, infection, and, invariably, scarring. The management of ulcerated hemangiomas is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/60/25546?source=see_link&amp;anchor=H12#H12\">",
"     \"Management of infantile hemangiomas\", section on 'Ulceration'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Bleeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although a common concern among parents, bleeding is rarely profuse and can generally be stopped with application of direct pressure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Airway hemangiomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Airway hemangiomas can develop in children who do not have cutaneous hemangiomas. However, the risk of airway hemangioma is higher with segmental hemangiomas located in a cervicofacial, mandibular, or \"beard\" distribution, which may include all or some of the following: the preauricular skin, mandible, lower lip, chin, or anterior neck (",
"    <a class=\"graphic graphic_picture graphicRef58168 \" href=\"mobipreview.htm?18/23/18815\">",
"     picture 11",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The possibility of airway hemangioma must be considered in any child who has a cutaneous hemangioma in a cervicofacial mandibular distribution and develops progressive hoarseness or stridor. Affected infants are most likely to experience symptoms between the ages of 6 and 12 weeks, when hemangioma proliferation is most rapid. Symptoms may progress from initial hoarseness or stridor to respiratory failure. Cough and cyanosis are other common manifestations. Airway involvement can be confirmed using endoscopic visualization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/81\">",
"     81",
"    </a>",
"    ]. The management of airway hemangiomas is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/60/25546?source=see_link\">",
"     \"Management of infantile hemangiomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Periorbital hemangiomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Periorbital hemangiomas may compromise normal visual development [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/82\">",
"     82",
"    </a>",
"    ]. The majority of hemangiomas that lead to visual complications involve the upper medial eyelid. However, a hemangioma of any size or morphology in the periorbital location may pose a threat to vision (",
"    <a class=\"graphic graphic_picture graphicRef50631 \" href=\"mobipreview.htm?41/12/42181\">",
"     picture 12",
"    </a>",
"    ). Subcutaneous periocular hemangiomas are of particular concern since they may extend deep into the orbit, causing exophthalmos or globe displacement with only subtle cutaneous manifestations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Astigmatism, the most common complication, results from direct pressure of the growing hemangioma on the cornea. Other potential problems include ptosis, proptosis, and strabismus. Stimulus-deprivation amblyopia, a result of physical obstruction of the visual axis by a hemangioma, is one of the leading causes of preventable blindness in children. Astigmatism, strabismus, and amblyopia are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/8/34951?source=see_link\">",
"     \"Evaluation and management of strabismus in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/61/8153?source=see_link&amp;anchor=H7#H7\">",
"     \"Overview of amblyopia\", section on 'Deprivational amblyopia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Early examination by an ophthalmologist familiar with periorbital hemangiomas and their potential complications is mandatory, since prolonged, severe visual compromise can result in permanent damage, including blindness. The management of periorbital hemangiomas is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/60/25546?source=see_link\">",
"     \"Management of infantile hemangiomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Other hemangiomas",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hemangiomas of the ear may obstruct the auditory canal, leading to otitis externa [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/83\">",
"       83",
"      </a>",
"      ]. Sensorineural hearing loss does not occur except in the very rare case of bilateral obstruction.",
"     </li>",
"     <li>",
"      Hemangiomas of the tongue, oral cavity, or aerodigestive tract may rarely interfere with eating, swallowing, or speech [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/11,12,83\">",
"       11,12,83",
"      </a>",
"      ]. Lesions in these locations that are significant enough to cause complications are much more often vascular malformations, not hemangiomas.",
"     </li>",
"     <li>",
"      Nuchal hemangiomas may temporarily impair range of motion of the neck.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Kasabach-Merritt phenomenon",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe thrombocytopenia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    coagulopathy that results from platelet trapping within a vascular tumor is called the Kasabach-Merritt phenomenon. Although children with large common hemangiomas were once thought to be at risk for this complication, the Kasabach-Merritt phenomenon is now known to be associated with two other types of vascular tumors: kaposiform hemangioendothelioma and tufted angioma, and is not associated with true infantile hemangiomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/39/44665/abstract/84,85\">",
"     84,85",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/9/14490?source=see_link&amp;anchor=H21#H21\">",
"     \"Neonatal thrombocytopenia\", section on 'Kasabach-Merritt syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/20/23873?source=see_link\">",
"       \"Patient information: Hemangioma (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infantile hemangiomas are the most common vascular tumors in infants and children. They are more common in girls than boys and among white non-Hispanic infants than among those of other",
"      <span class=\"nowrap\">",
"       racial/ethnic",
"      </span>",
"      groups. The incidence is increased in preterm infants. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The majority of hemangiomas are not clinically evident at birth but become apparent within the first days to months of life. Hemangiomas have a predilection for the head and neck, although they can occur anywhere in the skin, mucous membranes, or internal organs. They range in size from a few millimeters to many centimeters in diameter. They may be superficial, deep, or combined. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hemangiomas characteristically undergo a growth (proliferative) phase that is generally rapid for the first several months. The proliferative phase is followed by a spontaneous involution phase that typically begins after one year and lasts a variable number of years. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Natural history'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hemangiomas can be categorized as localized (or focal), segmental, or multiple:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Localized hemangiomas demonstrate clear, well-defined spatial containment, appear to arise from a single focus, and lack evidence of a linear or geometric pattern. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Localized lesions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Segmental hemangiomas are usually plaque-like and demonstrate a linear",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      geographic presence over a specific cutaneous territory (",
"      <a class=\"graphic graphic_picture graphicRef82212 \" href=\"mobipreview.htm?16/51/17200\">",
"       picture 6",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Segmental lesions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Multiple hemangiomas are arbitrarily defined as &ge;5 generally small, localized hemangiomas. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Multiple lesions'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most cutaneous hemangiomas are uncomplicated and require no intervention. However, some lesions may ulcerate, leading to pain, bleeding, scarring,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      infection. Other lesions may cause functional impairment during,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      disfigurement after, the proliferative phase (",
"      <a class=\"graphic graphic_table graphicRef50196 \" href=\"mobipreview.htm?33/24/34187\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/1\">",
"      Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol 1997; 13:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/2\">",
"      Bruckner AL, Frieden IJ. Hemangiomas of infancy. J Am Acad Dermatol 2003; 48:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/3\">",
"      Mulliken JB, Enjolras O. Congenital hemangiomas and infantile hemangioma: missing links. J Am Acad Dermatol 2004; 50:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/4\">",
"      Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006; 118:882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/5\">",
"      Kilcline C, Frieden IJ. Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol 2008; 25:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/6\">",
"      Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics 1976; 58:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/7\">",
"      Alper JC, Holmes LB. The incidence and significance of birthmarks in a cohort of 4,641 newborns. Pediatr Dermatol 1983; 1:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/8\">",
"      PRATT AG. Birthmarks in infants. AMA Arch Derm Syphilol 1953; 67:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/9\">",
"      JACOBS AH. Strawberry hemangiomas; the natural history of the untreated lesion. Calif Med 1957; 86:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/10\">",
"      Blei F, Walter J, Orlow SJ, Marchuk DA. Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch Dermatol 1998; 134:718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/11\">",
"      Chiller KG, Passaro D, Frieden IJ. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol 2002; 138:1567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/12\">",
"      Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med 1999; 341:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/13\">",
"      Hemangioma Investigator Group, Haggstrom AN, Drolet BA, et al. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr 2007; 150:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/14\">",
"      Enjolras O, Gelbert F. Superficial hemangiomas: associations and management. Pediatr Dermatol 1997; 14:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/15\">",
"      Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg 1983; 18:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/16\">",
"      Leon-Villapalos J, Wolfe K, Kangesu L. GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations. Br J Plast Surg 2005; 58:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/17\">",
"      North PE, Waner M, Mizeracki A, Mihm MC Jr. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000; 31:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/18\">",
"      North PE, Waner M, Mizeracki A, et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 2001; 137:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/19\">",
"      Barn&eacute;s CM, Huang S, Kaipainen A, et al. Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci U S A 2005; 102:19097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/20\">",
"      Yu Y, Fuhr J, Boye E, et al. Mesenchymal stem cells and adipogenesis in hemangioma involution. Stem Cells 2006; 24:1605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/21\">",
"      Boye E, Yu Y, Paranya G, et al. Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 2001; 107:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/22\">",
"      Walter JW, North PE, Waner M, et al. Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. Genes Chromosomes Cancer 2002; 33:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/23\">",
"      Nguyen VA, F&uuml;rhapter C, Romani N, et al. Infantile hemangioma is a proliferation of beta 4-negative endothelial cells adjacent to HLA-DR-positive cells with dendritic cell morphology. Hum Pathol 2004; 35:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/24\">",
"      Khan ZA, Boscolo E, Picard A, et al. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest 2008; 118:2592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/25\">",
"      Ritter MR, Reinisch J, Friedlander SF, Friedlander M. Myeloid cells in infantile hemangioma. Am J Pathol 2006; 168:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/26\">",
"      Bielenberg DR, Bucana CD, Sanchez R, et al. Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta. Int J Oncol 1999; 14:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/27\">",
"      Dadras SS, North PE, Bertoncini J, et al. Infantile hemangiomas are arrested in an early developmental vascular differentiation state. Mod Pathol 2004; 17:1068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/28\">",
"      Nguyen VA, Kutzner H, F&uuml;rhapter C, et al. Infantile hemangioma is a proliferation of LYVE-1-negative blood endothelial cells without lymphatic competence. Mod Pathol 2006; 19:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/29\">",
"      Yu Y, Flint AF, Mulliken JB, et al. Endothelial progenitor cells in infantile hemangioma. Blood 2004; 103:1373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/30\">",
"      Ritter MR, Dorrell MI, Edmonds J, et al. Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis. Proc Natl Acad Sci U S A 2002; 99:7455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/31\">",
"      Takahashi K, Mulliken JB, Kozakewich HP, et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 1994; 93:2357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/32\">",
"      Tan ST, Velickovic M, Ruger BM, Davis PF. Cellular and extracellular markers of hemangioma. Plast Reconstr Surg 2000; 106:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/33\">",
"      Jinnin M, Medici D, Park L, et al. Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med 2008; 14:1236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/34\">",
"      Claesson-Welsh L. Healing hemangiomas. Nat Med 2008; 14:1147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/35\">",
"      Chang E, Boyd A, Nelson CC, et al. Successful treatment of infantile hemangiomas with interferon-alpha-2b. J Pediatr Hematol Oncol 1997; 19:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/36\">",
"      Razon MJ, Kr&auml;ling BM, Mulliken JB, Bischoff J. Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation 1998; 5:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/37\">",
"      Ritter MR, Moreno SK, Dorrell MI, et al. Identifying potential regulators of infantile hemangioma progression through large-scale expression analysis: a possible role for the immune system and indoleamine 2,3 dioxygenase (IDO) during involution. Lymphat Res Biol 2003; 1:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/38\">",
"      Metry DW, Hebert AA. Benign cutaneous vascular tumors of infancy: when to worry, what to do. Arch Dermatol 2000; 136:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/39\">",
"      Frieden IJ, Eichenfield LF, Esterly NB, et al. Guidelines of care for hemangiomas of infancy. American Academy of Dermatology Guidelines/Outcomes Committee. J Am Acad Dermatol 1997; 37:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/40\">",
"      Hand JL, Frieden IJ. Vascular birthmarks of infancy: resolving nosologic confusion. Am J Med Genet 2002; 108:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/41\">",
"      Fishman SJ, Mulliken JB. Hemangiomas and vascular malformations of infancy and childhood. Pediatr Clin North Am 1993; 40:1177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/42\">",
"      Martinez-Perez D, Fein NA, Boon LM, Mulliken JB. Not all hemangiomas look like strawberries: uncommon presentations of the most common tumor of infancy. Pediatr Dermatol 1995; 12:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/43\">",
"      Enjolras O, Mulliken JB. The current management of vascular birthmarks. Pediatr Dermatol 1993; 10:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/44\">",
"      Chang LC, Haggstrom AN, Drolet BA, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008; 122:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/45\">",
"      Tollefson MM, Frieden IJ. Early growth of infantile hemangiomas: what parents' photographs tell us. Pediatrics 2012; 130:e314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/46\">",
"      Maguiness SM, Hoffman WY, McCalmont TH, Frieden IJ. Early white discoloration of infantile hemangioma: a sign of impending ulceration. Arch Dermatol 2010; 146:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/47\">",
"      Suh KY, Frieden IJ. Infantile hemangiomas with minimal or arrested growth: a retrospective case series. Arch Dermatol 2010; 146:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/48\">",
"      Haggstrom AN, Lammer EJ, Schneider RA, et al. Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 2006; 117:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/49\">",
"      Waner M, North PE, Scherer KA, et al. The nonrandom distribution of facial hemangiomas. Arch Dermatol 2003; 139:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/50\">",
"      Metry DW, Garzon MC, Drolet BA, et al. PHACE syndrome: current knowledge, future directions. Pediatr Dermatol 2009; 26:381.",
"     </a>",
"    </li>",
"    <li>",
"     PHACE Association. Online Mendelian Inheritance in Man (OMIM) website. OMIM entry #606519. www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM (Accessed on January 18, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/52\">",
"      Frieden IJ, Reese V, Cohen D. PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol 1996; 132:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/53\">",
"      Metry D, Heyer G, Hess C, et al. Consensus Statement on Diagnostic Criteria for PHACE Syndrome. Pediatrics 2009; 124:1447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/54\">",
"      Metry DW, Haggstrom AN, Drolet BA, et al. A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical findings, and complications. Am J Med Genet A 2006; 140:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/55\">",
"      Opitz JM, Gilbert EF. CNS anomalies and the midline as a \"developmental field\". Am J Med Genet 1982; 12:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/56\">",
"      Bhattacharya JJ, Luo CB, Alvarez H, et al. PHACES syndrome: a review of eight previously unreported cases with late arterial occlusions. Neuroradiology 2004; 46:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/57\">",
"      Metry DW, Dowd CF, Barkovich AJ, Frieden IJ. The many faces of PHACE syndrome. J Pediatr 2001; 139:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/58\">",
"      Haggstrom AN, Garzon MC, Baselga E, et al. Risk for PHACE syndrome in infants with large facial hemangiomas. Pediatrics 2010; 126:e418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/59\">",
"      Pascual-Castroviejo I. Vascular and nonvascular intracranial malformation associated with external capillary hemangiomas. Neuroradiology 1978; 16:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/60\">",
"      Pascual-Castroviejo I, Velez A, Pascual-Pascual SI, et al. Dandy-Walker malformation: analysis of 38 cases. Childs Nerv Syst 1991; 7:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/61\">",
"      Poindexter G, Metry DW, Barkovich AJ, Frieden IJ. PHACE syndrome with intracerebral hemangiomas, heterotopia, and endocrine dysfunction. Pediatr Neurol 2007; 36:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/62\">",
"      Burrows PE, Robertson RL, Mulliken JB, et al. Cerebral vasculopathy and neurologic sequelae in infants with cervicofacial hemangioma: report of eight patients. Radiology 1998; 207:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/63\">",
"      Drolet BA, Dohil M, Golomb MR, et al. Early stroke and cerebral vasculopathy in children with facial hemangiomas and PHACE association. Pediatrics 2006; 117:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/64\">",
"      Heyer GL, Dowling MM, Licht DJ, et al. The cerebral vasculopathy of PHACES syndrome. Stroke 2008; 39:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/65\">",
"      Hess CP, Fullerton HJ, Metry DW, et al. Cervical and intracranial arterial anomalies in 70 patients with PHACE syndrome. AJNR Am J Neuroradiol 2010; 31:1980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/66\">",
"      Reese V, Frieden IJ, Paller AS, et al. Association of facial hemangiomas with Dandy-Walker and other posterior fossa malformations. J Pediatr 1993; 122:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/67\">",
"      Duffy KJ, Runge-Samuelson C, Bayer ML, et al. Association of hearing loss with PHACE syndrome. Arch Dermatol 2010; 146:1391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/68\">",
"      McAtee-Smith J, Hebert AA, Rapini RP, Goldberg NS. Skin lesions of the spinal axis and spinal dysraphism. Fifteen cases and a review of the literature. Arch Pediatr Adolesc Med 1994; 148:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/69\">",
"      Goldberg NS, Hebert AA, Esterly NB. Sacral hemangiomas and multiple congenital abnormalities. Arch Dermatol 1986; 122:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/70\">",
"      Albright AL, Gartner JC, Wiener ES. Lumbar cutaneous hemangiomas as indicators of tethered spinal cords. Pediatrics 1989; 83:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/71\">",
"      Tubbs RS, Wellons JC 3rd, Iskandar BJ, Oakes WJ. Isolated flat capillary midline lumbosacral hemangiomas as indicators of occult spinal dysraphism. J Neurosurg 2004; 100:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/72\">",
"      Iacobas I, Burrows PE, Frieden IJ, et al. LUMBAR: association between cutaneous infantile hemangiomas of the lower body and regional congenital anomalies. J Pediatr 2010; 157:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/73\">",
"      Girard C, Bigorre M, Guillot B, Bessis D. PELVIS Syndrome. Arch Dermatol 2006; 142:884.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/74\">",
"      Metry DW, Hawrot A, Altman C, Frieden IJ. Association of solitary, segmental hemangiomas of the skin with visceral hemangiomatosis. Arch Dermatol 2004; 140:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/75\">",
"      Christison-Lagay ER, Burrows PE, Alomari A, et al. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg 2007; 42:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/76\">",
"      Lopriore E, Markhorst DG. Diffuse neonatal haemangiomatosis: new views on diagnostic criteria and prognosis. Acta Paediatr 1999; 88:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/77\">",
"      Boon LM, Burrows PE, Paltiel HJ, et al. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr 1996; 129:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/78\">",
"      Frieden IJ, Haggstrom AN, Drolet BA, et al. Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol 2005; 22:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/79\">",
"      Chamlin SL, Haggstrom AN, Drolet BA, et al. Multicenter prospective study of ulcerated hemangiomas. J Pediatr 2007; 151:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/80\">",
"      Kim HJ, Colombo M, Frieden IJ. Ulcerated hemangiomas: clinical characteristics and response to therapy. J Am Acad Dermatol 2001; 44:962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/81\">",
"      Orlow SJ, Isakoff MS, Blei F. Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a \"beard\" distribution. J Pediatr 1997; 131:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/82\">",
"      Ceisler EJ, Santos L, Blei F. Periocular hemangiomas: what every physician should know. Pediatr Dermatol 2004; 21:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/83\">",
"      Dinehart SM, Kincannon J, Geronemus R. Hemangiomas: evaluation and treatment. Dermatol Surg 2001; 27:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/84\">",
"      Enjolras O, Wassef M, Mazoyer E, et al. Infants with Kasabach-Merritt syndrome do not have \"true\" hemangiomas. J Pediatr 1997; 130:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/39/44665/abstract/85\">",
"      Osio A, Fraitag S, Hadj-Rabia S, et al. Clinical spectrum of tufted angiomas in childhood: a report of 13 cases and a review of the literature. Arch Dermatol 2010; 146:758.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5794 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-02DD474397-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_39_44665=[""].join("\n");
var outline_f43_39_44665=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Proliferation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Involution",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Natural history",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5833753\">",
"      - Proliferation and involution",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3163479\">",
"      - Infantile hemangiomas with minimal or arrested growth",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Localized lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Segmental lesions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - PHACE syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Lumbosacral lesions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Other associations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Multiple lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Visceral hemangiomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Ulceration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Bleeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Airway hemangiomas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Periorbital hemangiomas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Other hemangiomas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Kasabach-Merritt phenomenon",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/5794\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/5794|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?27/4/27716\" title=\"figure 1\">",
"      Pathogenesis hemangioma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/5794|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?11/7/11390\" title=\"picture 1\">",
"      Superficial hemangioma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?27/60/28623\" title=\"picture 2\">",
"      Deep hemangioma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/31/40434\" title=\"picture 3\">",
"      Hemangioma sharp margins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?0/32/512\" title=\"picture 4\">",
"      Lip hemangioma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?19/60/20416\" title=\"picture 5\">",
"      Infantile hemangioma - arrested growth",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?16/51/17200\" title=\"picture 6\">",
"      Segmental hemangioma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?18/46/19174\" title=\"picture 7\">",
"      PHACE syndrome 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?17/3/17471\" title=\"picture 8\">",
"      Lumbosacral hemangioma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?11/51/12095\" title=\"picture 9\">",
"      Ulcerated hemangioma perineum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?23/52/24384\" title=\"picture 10\">",
"      Ulcerated hemangioma axilla",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?18/23/18815\" title=\"picture 11\">",
"      Beard distribution hemangioma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?41/12/42181\" title=\"picture 12\">",
"      Periocular hemangioma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/5794|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/52/10059\" title=\"table 1\">",
"      PHACE syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?33/24/34187\" title=\"table 2\">",
"      IH features morbidity",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/23/5495?source=related_link\">",
"      Evaluation and diagnosis of infantile hemangiomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/8/34951?source=related_link\">",
"      Evaluation and management of strabismus in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/60/25546?source=related_link\">",
"      Management of infantile hemangiomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/9/14490?source=related_link\">",
"      Neonatal thrombocytopenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/61/8153?source=related_link\">",
"      Overview of amblyopia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/20/23873?source=related_link\">",
"      Patient information: Hemangioma (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/21/30038?source=related_link\">",
"      Vascular lesions in the newborn",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_39_44666="Pemphigus vulgaris - oral";
var content_f43_39_44666=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F57924%7EDERM%2F77462%7EDERM%2F53425%7EDERM%2F51868%7EDERM%2F63170%7EDERM%2F74842&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F57924%7EDERM%2F77462%7EDERM%2F53425%7EDERM%2F51868%7EDERM%2F63170%7EDERM%2F74842&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pemphigus vulgaris - oral lesions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple erosions on the&nbsp;palate in a patient with pemphigus vulgaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pemphigus vulgaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erosions on the tongue and lips are present in this patient with pemphigus vulgaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pemphigus vulgaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Flaccid bullae and erosions on the skin of a patient with pemphigus vulgaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pemphigus vulgaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erosions and small blisters are present in this image taken from a patient with pemphigus vulgaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pemphigus vulgaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple erosions on the trunk skin of this patient with pemphigus vulgaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pemphigus vulgaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Widespread erosions are present on the skin in this patient with pemphigus vulgaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_39_44666=[""].join("\n");
var outline_f43_39_44666=null;
var title_f43_39_44667="Risk factors for preeclampsia";
var content_f43_39_44667=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F61266&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F61266&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Factors associated with an increased risk of developing preeclampsia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Nulliparity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Preeclampsia in a previous pregnancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Age &gt;40 years or &lt;18 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Family history of preeclampsia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic hypertension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic renal disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Antiphospholipid antibody syndrome or inherited thrombophilia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vascular or connective tissue disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diabetes mellitus (pregestational and gestational)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Multifetal gestation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        High body mass index",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;Black race",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Male partner whose mother or previous partner had preeclampsia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hydrops fetalis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unexplained fetal growth restriction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Woman herself was small for gestational age",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fetal growth restriction, abruptio placentae, or fetal demise in a previous pregnancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prolonged interpregnancy interval",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span style=\"font-family: verdana,sans-serif; font-size: 10pt;\">",
"         Partner related factors (new partner,",
"         <span style=\"font-size: 13px;\">",
"          limted sperm exposure [eg,",
"         </span>",
"         previous use of barrier contraception])",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hydatidiform mole&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Susceptibility genes&nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    By comparison, smoking decreases the risk of preeclampsia",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_39_44667=[""].join("\n");
var outline_f43_39_44667=null;
var title_f43_39_44668="TNM distal cholangio";
var content_f43_39_44668=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F82369&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F82369&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    TNM staging system for distal cholangiocarcinoma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"4\">",
"       Primary tumor (T)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       TX",
"      </td>",
"      <td colspan=\"3\">",
"       Primary tumor cannot be assessed",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T0",
"      </td>",
"      <td colspan=\"3\">",
"       No evidence of primary tumor",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Tis",
"      </td>",
"      <td colspan=\"3\">",
"       Carcinoma in situ",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T1",
"      </td>",
"      <td colspan=\"3\">",
"       Tumor confined to the bile duct histologically",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T2",
"      </td>",
"      <td colspan=\"3\">",
"       Tumor invades beyond the wall of the bile duct",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T3",
"      </td>",
"      <td colspan=\"3\">",
"       Tumor invades the gallbladder, pancreas, duodenum, or other adjacent organs without involvement of the celiac axis, or the superior mesenteric artery",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T4",
"      </td>",
"      <td colspan=\"3\">",
"       Tumor involves the celiac axis, or the superior mesenteric artery",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"4\">",
"       Regional lymph nodes (N)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       NX",
"      </td>",
"      <td colspan=\"3\">",
"       Regional lymph nodes cannot be assessed",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       N0",
"      </td>",
"      <td colspan=\"3\">",
"       No regional lymph node metastasis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       N1",
"      </td>",
"      <td colspan=\"3\">",
"       Regional lymph node metastasis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"4\">",
"       Distant metastasis (M)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       M0",
"      </td>",
"      <td colspan=\"3\">",
"       No distant metastasis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       M1",
"      </td>",
"      <td colspan=\"3\">",
"       Distant metastasis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"4\">",
"       Anatomic stage/prognostic groups",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Stage 0",
"      </td>",
"      <td>",
"       Tis",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Stage IA",
"      </td>",
"      <td>",
"       T1",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Stage IB",
"      </td>",
"      <td>",
"       T2",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Stage IIA",
"      </td>",
"      <td>",
"       T3",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"3\">",
"       Stage IIB",
"      </td>",
"      <td>",
"       T1",
"      </td>",
"      <td>",
"       N1",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T2",
"      </td>",
"      <td>",
"       N1",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T3",
"      </td>",
"      <td>",
"       N1",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Stage III",
"      </td>",
"      <td>",
"       T4",
"      </td>",
"      <td>",
"       Any N",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Stage IV",
"      </td>",
"      <td>",
"       Any T",
"      </td>",
"      <td>",
"       Any N",
"      </td>",
"      <td>",
"       M1",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Note: cTNM is the clinical classification, pTNM is the pathologic classification.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer New York, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_39_44668=[""].join("\n");
var outline_f43_39_44668=null;
var title_f43_39_44669="Hormonal birth control PI";
var content_f43_39_44669=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F75100&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F75100&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Hormonal birth control",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"3\" width=\"33%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Method",
"       </td>",
"       <td class=\"subtitle1\">",
"        Using the method",
"       </td>",
"       <td class=\"subtitle1\">",
"        Some side effects and risks",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <p>",
"         <strong>",
"          Implantable rod",
"         </strong>",
"        </p>",
"        <p>",
"         Hormones it contains: Progestin",
"        </p>",
"        Expected pregnancies per 100 women in first year of use: Less than 1",
"       </td>",
"       <td>",
"        <p>",
"         Must be inserted by a doctor.",
"        </p>",
"        <p>",
"         Nothing to do or remember.",
"        </p>",
"        Lasts up to 3 years.",
"       </td>",
"       <td>",
"        Most common side effects:",
"        <ul>",
"         <li>",
"          Bleeding between periods",
"         </li>",
"         <li>",
"          Changes in periods",
"         </li>",
"        </ul>",
"        <br/>",
"        Other possible side effects:",
"        <ul>",
"         <li>",
"          Headache",
"         </li>",
"         <li>",
"          Acne",
"         </li>",
"         <li>",
"          Sore breasts",
"         </li>",
"         <li>",
"          Weight gain",
"         </li>",
"         <li>",
"          Mood changes",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <p>",
"         <strong>",
"          IUD with progestin",
"         </strong>",
"        </p>",
"        <p>",
"         Hormones it contains: Progestin",
"        </p>",
"        Expected pregnancies per 100 women in first year of use: Less than 1",
"       </td>",
"       <td>",
"        <p>",
"         Must be inserted by a doctor.",
"        </p>",
"        <p>",
"         Nothing to do or remember.",
"        </p>",
"        Lasts 3 to 5 years depending on type.",
"       </td>",
"       <td>",
"        Most common side effects:",
"        <ul>",
"         <li>",
"          Bleeding between periods",
"         </li>",
"         <li>",
"          Regular periods may stop",
"         </li>",
"        </ul>",
"        <br/>",
"        Other possible side effects:",
"        <ul>",
"         <li>",
"          Cramps",
"         </li>",
"        </ul>",
"        <br/>",
"        Potential but uncommon risks:",
"        <ul>",
"         <li>",
"          IUD can slip out",
"         </li>",
"         <li>",
"          IUD can damage the uterus",
"         </li>",
"         <li>",
"          Insertion of IUD can lead to a type of infection that can make it hard for a woman to get pregnant after the IUD is removed",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <p>",
"         <strong>",
"          Shot/injection",
"         </strong>",
"        </p>",
"        <p>",
"         Hormones it contains: Progestin",
"        </p>",
"        Expected pregnancies per 100 women in first year of use: 6",
"       </td>",
"       <td>",
"        Doctor or nurse must give you a shot every 3 months.",
"       </td>",
"       <td>",
"        Most common side effects:",
"        <ul>",
"         <li>",
"          Bleeding between periods",
"         </li>",
"         <li>",
"          Regular periods may stop",
"         </li>",
"        </ul>",
"        <br/>",
"        Other possible side effects:",
"        <ul>",
"         <li>",
"          Temporary bone thinning",
"         </li>",
"         <li>",
"          Weight gain",
"         </li>",
"         <li>",
"          Mood changes",
"         </li>",
"         <li>",
"          Hair loss or increased hair on face or body",
"         </li>",
"         <li>",
"          Sore breasts",
"         </li>",
"         <li>",
"          Headache",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <p>",
"         <strong>",
"          Progestin-only pill",
"         </strong>",
"        </p>",
"        <p>",
"         Hormones it contains: Progestin",
"        </p>",
"        Expected pregnancies per 100 women in first year of use: 9",
"       </td>",
"       <td>",
"        You must swallow a pill at the same time every day.",
"       </td>",
"       <td>",
"        Most common side effects:",
"        <ul>",
"         <li>",
"          Bleeding between periods (this is more common with progestin-only pills than with combined estrogen-progestin pills)",
"         </li>",
"        </ul>",
"        <br/>",
"        Other possible side effects:",
"        <ul>",
"         <li>",
"          Sore breasts",
"         </li>",
"         <li>",
"          Acne",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <p>",
"         <strong>",
"          Combination estrogen-progestin pill",
"         </strong>",
"        </p>",
"        <p>",
"         Hormones it contains: Progestin and estrogen",
"        </p>",
"        Expected pregnancies per 100 women in first year of use: 9",
"       </td>",
"       <td>",
"        You must swallow a pill every day.",
"       </td>",
"       <td>",
"        Most common side effects:",
"        <ul>",
"         <li>",
"          Bleeding between periods",
"         </li>",
"         <li>",
"          Decreased bleeding during period",
"         </li>",
"        </ul>",
"        <br/>",
"        Other possible side effects:",
"        <ul>",
"         <li>",
"          Nausea",
"         </li>",
"         <li>",
"          Changes in mood",
"         </li>",
"        </ul>",
"        <br/>",
"        Rare but serious risks include:",
"        <ul>",
"         <li>",
"          Heart attack",
"         </li>",
"         <li>",
"          Stroke",
"         </li>",
"         <li>",
"          Blood clots",
"         </li>",
"         <li>",
"          High blood pressure",
"         </li>",
"         <li>",
"          Liver tumors",
"         </li>",
"         <li>",
"          Gallstones",
"         </li>",
"         <li>",
"          Yellowing of the skin or eyes (jaundice)",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <p>",
"         <strong>",
"          Patch",
"         </strong>",
"        </p>",
"        <p>",
"         Hormones it contains: Progestin and estrogen",
"        </p>",
"        Expected pregnancies per 100 women in first year of use: 9",
"       </td>",
"       <td>",
"        You must wear a patch on your skin all the time for 3 weeks. Every week, you change the patch. During the fourth week, you go without a patch.",
"       </td>",
"       <td>",
"        Side effects and risks similar to those of combined estrogen-progestin pills, but the patch causes higher average levels of estrogen than most pills. This may increase the risk of blood clots.",
"        <br/>",
"        <br/>",
"        Other possible side effects:",
"        <ul>",
"         <li>",
"          Skin irritation where patch is applied",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         <strong>",
"          Vaginal ring",
"         </strong>",
"        </p>",
"        <p>",
"         Hormones it contains: Progestin and estrogen",
"        </p>",
"        Expected pregnancies per 100 women in first year of use: 9",
"       </td>",
"       <td>",
"        You must put the ring into your vagina and leave it in for 3 weeks. During the fourth week, you go without a ring.",
"       </td>",
"       <td>",
"        Side effects and risks similar to those of combined estrogen-progestin pill. (Breast soreness and nausea may be less than with the pill.)",
"        <br/>",
"        <br/>",
"        Other possible side effects:",
"        <ul>",
"         <li>",
"          Vaginal discharge or irritation",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    The methods listed here all require a prescription. This table applies to women without medical problems, such as a history of cancer, blood clots, or liver disease. If you have any medical problems, ask your doctor or nurse whether you should avoid any type of hormonal birth control. If you are breastfeeding, mention that to your doctor or nurse when you choose birth control.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_39_44669=[""].join("\n");
var outline_f43_39_44669=null;
var title_f43_39_44670="Solute clearance over time PD";
var content_f43_39_44670=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F71878&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F71878&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Graphs showing the total solute clearance among CAPD patients as measured by weekly Kt/V and creatinine clearance",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 425px; height: 442px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Total solute clearance over time, as measured by weekly Kt/V (top panel) and creatinine clearance (CCr, lower panel), in patients on continuous peritoneal dialysis. Although peritoneal clearance (middle columns) remains constant, total clearance (left columns) falls because of a progressive loss in residual renal function (RRF, right columns).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Burkart, JM, Schreiber, M, Korbet, SM, et al, Perit Dial Int 1996; 16:457.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_39_44670=[""].join("\n");
var outline_f43_39_44670=null;
var title_f43_39_44671="Normal LV pressure";
var content_f43_39_44671=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F56029&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F56029&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left ventricular pressure tracing",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 185px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal left ventricular pressure tracing recorded with a 40 mmHg scale; electrocardiographic leads II and aVL are recorded simultaneously. With rapid filling of the left ventricle at the onset of diastole, there is a gradual increase in pressure, culminating with left atrial contraction and an \"a\" wave. The pressure just prior to the onset of left ventricular systole is the left ventricular end-distolic pressure (LVEDP).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Kern MJ. ACC Current Journal Review, in press, 1997.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_39_44671=[""].join("\n");
var outline_f43_39_44671=null;
